Quarterly Report • Aug 7, 2025
Quarterly Report
Open in ViewerOpens in native device viewer
KBC Group – Investor Relations Office: [email protected]
KBC Group I Quarterly Report – 2Q2025 I p.1

Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Analysis of year-to-date period 9 ESG developments, risk statement and economic views 10 Our guidance 12 Consolidated financial statements Consolidated income statement 14
Consolidated statement of comprehensive income 15 Consolidated balance sheet 17 Consolidated statement of changes in equity 18 Consolidated cash flow statement 20 Notes to the accounting policies 22 Notes on segment reporting 23 Other notes 25 Additional information Credit risk 39 Solvency 43
Income statement, volumes and ratios per business unit 49 Details of ratios and terms 57
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
'I Bartel Puelinckx, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
[email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 7 August 2025
KBC Group I Quarterly Report – 2Q2025 I p.2
| KBC Group – overview (consolidated, IFRS) | 2Q2025 | 1Q2025 | 2Q2024 | 1H2025 | 1H2024 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 1 018 | 546 | 925 | 1 564 | 1 431 |
| Basic earnings per share (in EUR) | 2.50 | 1.32 | 2.25 | 3.82 | 3.44 |
| Breakdown of the net result by business unit (in millions of EUR) |
|||||
| Belgium | 607 | 281 | 519 | 888 | 761 |
| Czech Republic | 240 | 207 | 244 | 447 | 441 |
| International Markets | 237 | 135 | 224 | 372 | 370 |
| Group Centre | -65 | -77 | -61 | -143 | -141 |
| Parent shareholders' equity per share (in EUR, end of period) |
58.9 | 58.8 | 53.2 | 58.9 | 53.2 |
'We recorded an excellent net profit of 1 018 million euros in the second quarter of 2025. Compared to the result for the previous quarter, our total income benefited from several factors, including the sharp increase in net interest income, higher insurance income, better trading and fair value income and the seasonal peak in dividend income, while net fee and commission income – though still at a high level – was down somewhat quarter-on-quarter.
Our loan portfolio continued to expand, increasing by 2% quarter-on-quarter and by 7% year-on-year. Customer deposits – excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches – were also up 2% quarter-on-quarter and 7% year-onyear.
Operating expenses were down significantly on their level in the previous quarter, due to the fact that the bulk of bank and insurance taxes for the full year were recorded – as usual – in the first quarter. Disregarding bank and insurance taxes, operating expenses were up by 2% quarter-on-quarter. Insurance service expenses after reinsurance were down, whereas loan loss impairment charges increased, though the credit cost ratio for the first six months of 2025 remained at a favourable level of 15 basis points, well below the through-the-cycle value of 25-30 basis points.
Consequently, when adding up the results for the first and second quarters of the year, our net profit for the first half of 2025 amounted to 1 564 million euros, up 9% on the year-earlier figure.
Our solvency position remained strong, with an unfloored fully loaded common equity ratio under Basel IV of 14.6% at the end of June 2025. Our liquidity position remained very solid too, as illustrated by an LCR of 157% and an NSFR of 135%. In line with our dividend policy, we will pay out an interim dividend of 1 euro per share in November 2025 as an advance on the total dividend for financial year 2025. Furthermore, we also decided to increase our guidance for net interest income for full-year 2025 to at least 5.85 billion euros, up from our initial guidance of 5.7 billion euros, as well as our guidance for 2025 total income growth to at least 7%, up from our initial guidance of 5.5%.
We continue to lead the way in digital innovation, with Kate playing a pivotal role in delivering smarter, faster, and more personal safe and trusted services to our customers. Today, 5.7 million customers use Kate, that's 19% more than one year ago. Operationally, Kate now autonomously resolves 7 out of 10 customer queries across our core markets. That's equivalent to the workload of over 300 full-time employees, allowing our teams to focus on more complex and valuable customer conversations.
Our ambition remains clear: to be the reference bank-insurer in all our home markets. We pursue that goal not only through a strong, customer-focused business model, but above all thanks to the trust placed in us by our customers, employees, shareholders and other stakeholders. That trust means a lot to us – and I want to thank you sincerely for it.'

Johan Thijs Chief Executive Officer

Net interest income increased by 6% quarter-on-quarter and by 9% year-on-year. The net interest margin for the quarter under review amounted to 2.08%, up 2 basis points on the previous quarter and down 2 basis points year-on-year. Customer loan volumes increased by 2% quarter-on-quarter and by 7% year-on-year. Customer deposits, excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches, also went up by 2% quarter-on-quarter and 7% year-on-year.
The insurance service result (insurance revenues before reinsurance - insurance service expenses before reinsurance + net result from reinsurance contracts held) amounted to 166 million euros (up on the 142 million euros and 113 million euros recorded in the previous and year-earlier quarters, respectively) and breaks down into 113 million euros for non-life insurance and 53 million euros for life insurance. The non-life insurance combined ratio for the first half of 2025 came to an excellent 85%, compared to 90% for full-year 2024. Sales of non-life insurance products increased by 8% year-on-year, while life insurance sales were down 35% on the very high level recorded in the previous quarter and up 6% on their level in the year-earlier quarter.
Net fee and commission income was down 3% on its high level in the previous quarter, due mainly to lower fees from asset management activities caused by a lower average asset base and some seasonality, combined with lower fees for banking services. Net fee and commission income was still up 7% year-on-year, thanks to higher fees for both asset management and banking services.
Trading & fair value income and insurance finance income and expense was up 11 million euros but down 37 million euros on the figures for the previous and year-earlier quarters, respectively. Net other income was above its normal run rate due mainly to higher-than-average gains on the sale of real estate. Dividend income was up on the previous quarter's level, since the bulk of dividend income is traditionally received in the second quarter.
Operating expenses excluding bank and insurance taxes were up 2% quarter-on-quarter and 5% year-on-year. Bank and insurance taxes were down significantly on the previous quarter as the first quarter of the year traditionally includes the bulk of bank and insurance taxes for the full year. The cost/income ratio for the first six months of 2025 came to 45%, compared to 47% for full-year 2024. In that calculation, certain non-operating items have been excluded and bank and insurance taxes spread evenly throughout the year. When excluding all bank and insurance taxes, the cost/income ratio for the first six months of 2025 amounted to 41%, compared to 43% for full-year 2024.
Loan loss impairment charges increased to 116 million euros, compared to 38 million euros in the previous quarter and 72 million euros in the year-earlier quarter. The quarter-on-quarter increase was due entirely to the change in the reserve for geopolitical and macroeconomic uncertainties (up 40 million euros in the quarter under review, as opposed to a release of 45 million euros in the previous quarter). The credit cost ratio for the first six months of 2025 amounted to 0.15%, compared to 0.10% for full-year 2024. Impairment on assets other than loans amounted to 8 million euros, compared to virtually zero in the previous quarter and 13 million euros in the second quarter of 2024.
Our liquidity position remained strong, with an LCR of 157% and NSFR of 135%. Our capital base remained robust, with an unfloored fully loaded common equity ratio of 14.6%*.

* For the fully loaded common equity ratio as of 2025, KBC focuses on the so-called unfloored fully loaded common equity ratio, which takes into account the total risk-weighted asset impact of Basel IV, excluding the output floor impact.
| KBC Group (simplified; in millions of EUR) | 2Q2025 | 1Q2025 | 4Q2024 | 3Q2024 | 2Q2024 | 1H2025 | 1H2024 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 509 | 1 421 | 1 433 | 1 394 | 1 379 | 2 930 | 2 748 |
| Insurance revenues before reinsurance | 788 | 773 | 764 | 740 | 726 | 1 561 | 1 441 |
| Non-life | 667 | 648 | 640 | 631 | 613 | 1 316 | 1 211 |
| Life | 121 | 125 | 124 | 109 | 114 | 246 | 230 |
| Dividend income Net result from financial instruments at fair value |
33 | 9 | 13 | 11 | 26 | 42 | 33 |
| through P&L and Insurance finance income and expense |
-34 | -45 | -74 | -42 | 3 | -79 | -52 |
| Net fee and commission income | 667 | 690 | 700 | 641 | 623 | 1 357 | 1 237 |
| Net other income | 77 | 67 | 27 | 45 | 51 | 143 | 109 |
| Total income | 3 041 | 2 915 | 2 863 | 2 787 | 2 809 | 5 955 | 5 516 |
| Operating expenses (excl. directly attributable from insurance) |
-1 020 | -1 498 | -1 126 | -1 058 | -950 | -2 518 | -2 381 |
| Total operating expenses excluding bank and insurance taxes |
-1 125 | -1 106 | -1 201 | -1 135 | -1 074 | - 2 232 | -2 137 |
| Total bank and insurance taxes | -27 | -539 | -55 | -47 | -2 | -566 | -521 |
| Minus: operating expenses allocated to insurance | 132 | 148 | 131 | 124 | 126 | 280 | 276 |
| service expenses Insurance service expenses before reinsurance |
-608 | -622 | -635 | -688 | -590 | -1 230 | -1 152 |
| Of which Insurance commission paid | -105 | -102 | -103 | -99 | -92 | -206 | -181 |
| Non-Life | -541 | -543 | -561 | -615 | -514 | -1 084 | -1 003 |
| Life | -67 | -79 | -74 | -72 | -76 | -146 | -149 |
| Net result from reinsurance contracts held | -15 | -9 | -4 | 28 | -24 | -24 | -41 |
| Impairment | -124 | -38 | -78 | -69 | -85 | -162 | -101 |
| Of which: on financial assets at amortised cost and at fair | -116 | -38 | -50 | -61 | -72 | -155 | -88 |
| value through other comprehensive income1 Share in results of associated companies & joint |
1 | 0 | -1 | 78 | 2 | 2 | 2 |
| ventures Result before tax |
1 275 | 747 | 1 020 | 1 079 | 1 162 | 2 022 | 1 842 |
| Income tax expense | -257 | -202 | 96 | -211 | -237 | -458 | -412 |
| Result after tax | 1 018 | 546 | 1 115 | 868 | 925 | 1 564 | 1 431 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 1 018 | 546 | 1 116 | 868 | 925 | 1 564 | 1 431 |
| Basic earnings per share (EUR) Diluted earnings per share (EUR) |
2.50 2.50 |
1.32 1.32 |
2.75 2.75 |
2.14 2.14 |
2.25 2.25 |
3.82 3.82 |
3.44 3.44 |
| Key consolidated balance sheet figures, IFRS, | |||||||
| KBC Group (in millions of EUR) | 30-06-2025 | 31-03-2025 | 31-12-2024 | 30-09-2024 | 30-06-2024 | ||
| Total assets | 390 669 | 380 313 | 373 048 | 353 261 | 361 945 | ||
| Loans & advances to customers | 202 031 | 197 326 | 192 067 | 188 623 | 187 502 | ||
| Securities (equity and debt instruments) | 85 490 | 84 419 | 80 339 | 75 929 | 73 941 | ||
| Deposits from customers | 236 626 | 231 022 | 228 747 | 221 851 | 221 844 | ||
| Insurance contract liabilities | 17 022 | 16 912 | 17 111 | 17 012 | 16 521 | ||
| Liabilities under investment contracts, insurance | 15 757 | 15 631 | 15 671 | 15 193 | 14 780 | ||
| Total equity | 26 229 | 25 191 | 24 311 | 23 300 | 22 936 | ||
| Selected ratios for KBC Group (consolidated) | 1H2025 | FY2024 | |||||
| Return on equity2 | 13% | 15% | |||||
| Cost/income ratio, group - excl. non-operating items and evenly spreading bank and insurance taxes throughout the year - excl. all bank and insurance taxes |
45% 41% |
47% 43% |
|||||
| Combined ratio, non-life insurance | 85% | 90% | |||||
| Common equity ratio (CET1), fully loaded (Basel IV as of 2025, Danish Compromise, unfloored3) |
14.6% | 15.0% | |||||
| Credit cost ratio4 | 0.15% | 0.10% | |||||
| Impaired loans ratio | 1.8% | 2.0% | |||||
| for loans more than 90 days past due | 1.0% | 1.0% |
1 Also referred to as 'Loan loss impairment'. Liquidity coverage ratio (LCR) 157% 158%
Net stable funding ratio (NSFR) 135% 139%
2 15% for the first half of 2025 (and 14% for full-year 2024), when non-operating items are excluded and bank and insurance taxes spread evenly throughout the year.
3 For the fully loaded common equity ratio as of 2025, KBC focuses on the so-called unfloored fully loaded common equity ratio, which takes into account the total risk-weighted asset impact of
Basel IV, excluding the output floor impact. 4 A negative figure indicates a net impairment release (positively affecting results).
+4% quarter-on-quarter and +8% year-on-year
Net interest income amounted to 1 509 million euros, up 6% quarter-on-quarter and 9% year-on-year.
The quarter-on-quarter increase was due to factors such as the positive impact of a higher commercial transformation result, the higher level of income from lending activities (strong loan volume growth, partly offset by the negative impact of pressure on loan margins in some core markets), higher net interest income from inflation-linked bonds, increased interest income from dealing room activities, a greater number of days in the period under review, and lower subordinated funding costs. These items were partially offset by a lower level of interest income from customer term deposits (owing to a shift from term deposits to savings accounts) and from short-term cash management activities.
The year-on-year increase was due to a combination of a significantly higher commercial transformation result, a higher level of income from lending activities and increased interest income from dealing room activities. These items were partly offset by a lower level of interest income from customer term deposits, lower net interest income from inflation-linked bonds and a lower level of interest income from short-term cash management activities.
The net interest margin for the quarter under review amounted to 2.08%, up 2 basis points quarter-on-quarter but down 2 basis points year-on-year (due to the reasons mentioned above combined with an increase of the interest-bearing asset base). Customer loan volume amounted to 202 billion euros and was up 2% quarter-on-quarter and 7% year-on-year, with increases in every core country. Customer deposits amounted to 237 billion euros, up 2% quarter-on-quarter and 6% year-on-year. When excluding volatile, low-margin short-term deposits at KBC Bank's foreign branches (driven by short-term cash management opportunities), customer deposits were up 2% quarter-on-quarter and 7% year-on-year. The growth figures above exclude the forex-related impact.
For guidance regarding expected net interest income in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
The insurance service result (insurance revenues before reinsurance – insurance service expenses before reinsurance + net result from reinsurance contracts held; the two latter items are not part of total income) amounted to 166 million euros and breaks down into 113 million euros for non-life insurance and 53 million euros for life insurance.
The non-life insurance service result went up by 17% quarter-on-quarter, owing primarily to higher insurance revenues and marginally lower insurance service expenses, partly offset by a worse reinsurance result. It was up 49% year-on-year thanks to much higher insurance revenues and a better reinsurance result, only partially offset by higher insurance service expenses. The life insurance service result was up 17% quarter-on-quarter, essentially due to lower insurance service expenses. It was up 42% yearon-year, thanks to a combination of higher insurance revenues and lower insurance service expenses.
The combined ratio of the non-life insurance activities amounted to an excellent 85% in the first half of 2025, compared to 90% for full-year 2024. At 671 million euros, non-life insurance sales were up 8% year-on-year, with growth in all countries and all main classes. At 655 million euros, sales of life insurance products were down 35% on the level recorded in the previous quarter (which had included very high sales of unit-linked insurance products, attributable to the successful launch of structured issues in Belgium in the first quarter of 2025) and up 6% on the level recorded in the year-earlier quarter (with higher sales of interest-guaranteed and hybrid products more than offsetting the drop in unit-linked insurance sales). Overall, the share of guaranteed-interest products and unit-linked products in our life insurance sales in the quarter under review amounted to 46% and 43%, respectively, with hybrid products (mainly in Belgium and the Czech Republic) accounting for the remainder.
For guidance regarding expected insurance revenues and the combined ratio in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
Net fee and commission income amounted to 667 million euros, down 3% quarter-on-quarter but up 7% year-on-year. The decrease on the high level in the previous quarter was mainly accounted for by fees related to asset management activities (due in part to the effect of a lower average asset base and seasonally lower entry fees, and despite good net inflows in the quarter under review) and, to a lesser extent, by fees related to banking activities (following a strong first quarter). The year-on-year increase in net fee and commission income was attributable to higher fees for asset management activities (mainly increased management fees) and banking services (primarily payments and securities).
At the end of June 2025, our total assets under management amounted to 280 billion euros, up 3% quarter-on-quarter thanks to a positive market performance in the quarter (+2 percentage points) combined with the positive impact of net inflows (+1 percentage point). Assets under management grew by 7% year-on-year, with net inflows accounting for 4 percentage points and the positive market performance during the year for 3 percentage points.
Trading & fair value income and insurance finance income and expense amounted to -34 million euros, up 11 million euros quarter-on-quarter but down 37 million euros year-on-year. The quarter-on-quarter increase was due to the positive change in 'market value of derivatives used for asset/liability management purposes and other', partially offset by a lower dealing room result, whereas the year-on-year decrease was due mainly to the negative change in the 'market value of derivatives used for asset/liability management purposes and other'.
The other remaining income items included dividend income of 33 million euros (up significantly on the previous quarter since the bulk of dividend income is traditionally received in the second quarter) and net other income of 77 million euros (higher than its 50 million-euro normal run rate, as it included higher-than-average gains on the sale of real estate).
Operating expenses excluding bank and insurance taxes amounted to 1 125 million euros in the second quarter of 2025, up 2% on their level in the previous quarter and up 5% year-on-year*. The quarter-on-quarter increase was due mainly to higher staff costs, higher ICT costs and seasonally higher marketing expenses. The year-on-year increase was primarily accounted for by higher staff costs, ICT costs and depreciation expenses.
Bank and insurance taxes in the quarter under review amounted to 27 million euros, down significantly on the 539 million euros recorded in the previous quarter, as the bulk of the bank and insurance taxes for the full year is traditionally recorded in the first quarter of the year. Year-on-year, bank and insurance taxes were up 24 million euros, owing mainly to the partial reversal of the contribution to the deposit guarantee fund in Belgium in the second quarter of 2024.
When certain non-operating items are excluded and bank and insurance taxes spread evenly throughout the year, the cost/income ratio for the first six months of 2025 amounted to 45%, compared to 47% for full-year 2024. When excluding all bank and insurance taxes, the cost-income ratio amounted to 41%, compared to 43% for full-year 2024.
For guidance regarding expected operating expenses in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
* Note that operating expenses excluding bank and insurance taxes were low in the first half of 2024, hence we feel comfortable with our full year 2025 guidance of growth for operating expenses excluding bank and insurance taxes of below 2.5% year-on-year.
versus a 38-million-euro net charge in the previous quarter and a 72-million-euro net charge in the year-earlier quarter
In the quarter under review, we recorded a 116-million-euro net loan loss impairment charge, compared to a net charge of 38 million euros in the previous quarter and 72 million euros in the year-earlier quarter. Of the net impairment charge in the quarter under review, 76 million euros related to the loan book (compared to 83 million euros, of which 41 million euros related to lowering the backstop shortfall for old non-performing loans in Belgium, in the previous quarter) and 40 million euros to an update of the reserve for geopolitical and macroeconomic uncertainties due to a management overlay (compared to a release of 45 million euros in the previous quarter). As a consequence, the outstanding reserve for geopolitical and macroeconomic uncertainties amounted to 112 million euros at the end of June 2025.
The resulting credit cost ratio amounted to 0.15% for the first six months of 2025 (likewise 0.15% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties), compared to 0.10% for full-year 2024 (0.16% excluding the changes in the reserve for geopolitical and macroeconomic uncertainties). At the end of June 2025, 1.8% of our total loan book was classified as impaired ('Stage 3'), compared to 2.0% at year-end 2024. Impaired loans that are more than 90 days past due amounted to 1.0% of the loan book, the same as at year-end 2024.
For guidance regarding the expected credit cost ratio in 2025 and the years to come, please refer to the section entitled 'Our guidance'.
Impairment charges on assets other than loans amounted to 8 million euros in the quarter under review, compared to virtually zero in the previous quarter and 13 million euros in the year-earlier quarter. The figure for the quarter under review mainly includes the impairment charges related to modification losses on the extended interest rate cap regulation in Hungary and impairment charges on software.
Belgium 607 million euros; Czech Rep. 240 million euros; International Markets 237 million euros; Group Centre -65 million euros
Belgium: at first sight, the net result (607 million euros) was more than double the result for the previous quarter. However, when excluding bank and insurance taxes (the bulk of which for the full year is recorded in the first quarter and hence distorts the quarteron-quarter comparison), the net result increased slightly by 1% quarter-on-quarter, due to the combined effect of:
• higher total income (accounted for mainly by increased net interest income, net other income and the seasonal peak in dividend income, partially offset by lower trading & fair value income and net fee and commission income);
Czech Republic: at first sight, the net result (240 million euros) was up 16% on the result for the previous quarter. However, when excluding bank and insurance taxes, the net result was up 4% quarter-on-quarter, due to the combined effect of:
International Markets: the 237-million-euro net result breaks down as follows: 25 million euros in Slovakia, 122 million euros in Hungary and 90 million euros in Bulgaria. For the business unit as a whole, the net result was, at first glance, up 75% on the previous quarter's result. However, when excluding bank and insurance taxes, the net result fell slightly by 3% quarter-on-quarter, due to the combined effect of:
Group Centre: the net result (-65 million euros) was 12 million euros higher than the figure recorded in the previous quarter, due in part to higher trading & fair value income, partially offset by higher costs.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 1H2025 | FY2024 | 1H2025 | FY2024 | 1H2025 | FY2024 |
| Cost/income ratio - excl. non-operating items and evenly spreading bank and insurance taxes throughout the year - excl. all bank and insurance taxes |
43% 39% |
44% 41% |
42% 41% |
45% 43% |
45% 37% |
46% 38% |
| Combined ratio, non-life insurance | 86% | 88% | 83% | 86% | 89%2 | 96%2 |
| Credit cost ratio1 | 0.14% | 0.19% | 0.12% | -0.09% | 0.19% | -0.08% |
| Impaired loans ratio | 1.9% | 2.0% | 1.3% | 1.3% | 1.5% | 1.6% |
1 A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report. 2 Excluding windfall insurance taxes in Hungary, the combined ratio amounted to 93% for full-year 2024 and 85% for the first six months of 2025.
At the end of June 2025, total equity came to 26.2 billion euros and comprised 23.3 billion euros in parent shareholders' equity and 2.9 billion euros in additional tier-1 instruments. Total equity was up 1.9 billion euros on its level at the end of 2024. This was due to the combined effect of:
We have provided details of these changes under 'Consolidated statement of changes in equity' in the 'Consolidated financial statements' section of the quarterly report.
In the first six months of 2025, risk-weighted assets rose by 6.3 billion euros to 126.2 billion euros, driven primarily by the application of Basel IV and volume growth.
Our solvency position remained strong, as illustrated by an unfloored fully loaded common equity ratio (CET1) of 14.6% under Basel IV at 30 June 2025, compared to 15.0% under Basel III at the end of December 2024 (corresponding to14.6% under Basel IV). The solvency ratio for KBC Insurance under the Solvency II framework was 213% at the end of June 2025, compared to 200% at the end of 2024. We have provided more details on solvency under 'Solvency' in the 'Additional information' section of the quarterly report. We estimate that the acquisition of 365.bank in Slovakia, which was announced in the previous quarter, will have an impact of -50 basis points on our unfloored fully loaded common equity ratio when completed (expected before the end of 2025).
The dividend policy and capital deployment policy are explained in the 'Our guidance' section of this report. In line with that policy, we will pay an interim dividend of 1 euro per share in November 2025 as an advance on the total dividend for financial year 2025.
Our liquidity position also remained excellent, as reflected in an LCR ratio of 157% and an NSFR ratio of 135%, compared to 158% and 139%, respectively, at the end of 2024, well above the regulatory minima of 100%.
up 9% year-on-year
Highlights (compared to the first six months of 2024, unless otherwise stated):
KBC continues to stride forward in its sustainability journey, together with its customers, employees and other stakeholders. We share sustainability information in a transparent and consistent manner. Since this year, we have done so in a dedicated Sustainability Statement in our Annual Report, as well as in our voluntary Sustainability Report. Both publications are available at www.kbc.com.
We have received broad recognition for our transparent sustainability communication in the form of several sustainability-related awards and ESG ratings. For example, we have been included in the S&P Global Yearbook and remain a FTSE4Good Index Series constituent. Furthermore, K&H in Hungary, UBB in Bulgaria and KBC Bank in Belgium all recently received the Euromoney Award for Best Bank for ESG in their respective countries.
These acknowledgements reflect the group's continued commitment to integrating environmental, social, and governance principles across its operations and strategy. They also highlight our strong performance in sustainability and reaffirm our position as a leader in responsible business practices.
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of factors are considered to constitute the main challenges for the financial sector. These stem primarily from geopolitical risks which have increased significantly over the past few years (including the war in Ukraine, conflicts in the Middle East and trade wars as a consequence of US tariff policies). These risks result or may result in shocks for the global economic system (e.g., GDP and inflation) and the financial markets (including interest rates). European economies, including KBC's home markets, are affected too, creating an uncertain business environment, including for financial institutions. Regulatory and compliance risks (in relation to capital requirements, anti-money laundering regulations, GDPR and ESG/sustainability) also remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology, including AI, as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate and environmental-related risks are becoming increasingly prevalent. Cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole. The war in Ukraine and geopolitical tensions in general have triggered an increase in attacks worldwide. Finally, we have seen governments across Europe taking additional measures to support their budgets (via increased tax contributions from the financial sector) and their citizens and corporate sector (by, for instance, implementing interest rate caps on loans or by pushing for higher rates on savings accounts).
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.

KBC Group I Quarterly Report – 2Q2025 I p.10
US economic activity rose by 0.7% (non-annualised) in the second quarter of 2025, compared to negative growth of -0.1% in the first quarter of 2025. The rebound was largely attributable to resilient consumer demand and net exports. As a result of recent US economic policy – specifically with respect to import tariffs – growth in the US is expected to slow down again and to stagnate in the third quarter, before moderately recovering.
Euro area growth in the second quarter amounted to 0.1%, after 0.6% had been recorded in the first quarter of 2025. Notwithstanding the US-EU tariff agreement of 27 July, uncertainty surrounding economic policy and trade relations are likely to keep economic growth in the euro area subdued in the next few quarters. Meanwhile, the medium-term growth outlook has improved somewhat on the back of expected defence spending and infrastructure investments.
Quarter-on-quarter growth in Belgium was 0.2% in the second quarter, markedly weaker than in the previous quarter. Relatively strong domestic demand still remains the most important contributor to economic growth. For the next few quarters, we expect growth to remain broadly in line with that of the euro area.
The Czech economy grew by 0.2% in the second quarter, down from the 0.7% recorded in the first quarter of 2025, due to a weak industrial recovery. Hungarian economic activity rebounded by 0.4% in the second quarter after a decline of 0.1% in the first quarter. In Bulgaria and Slovakia, second-quarter real GDP growth was relatively resilient at 0.5% and 0.3%, respectively.
The main risk to our short-term outlook for European growth is a further escalation of the ongoing global trade conflict. Of particular concern is the continued threat of new US policy actions (even after the US-EU tariff agreement) and EU countermeasures to this and to the potential trade diversion of Chinese export goods away from the US market towards the EU.
In the euro area, inflation hit 2.0% in July, with core inflation remaining steady at 2.3%. Disinflationary pressures exerted by lower energy prices, the negative demand shock caused by US trade tariffs and the strength of the euro are likely to persist in the coming months. In the US, both headline and core inflation picked up in June, increasing to 2.7% and 2.9%, respectively. US inflation is likely to increase further in the course of 2025, as a consequence of the import tariffs imposed by the government there.
The ECB continued its easing cycle and cut its deposit rate in January, March, April and June 2025 to its current level of 2.0%. We expect the ECB to cut rates one more time in September, followed by a period of unchanged policy rates.
The Fed kept its easing cycle on pause in the first half of the year amidst economic uncertainty, especially about the inflationary and growth impact of higher import tariffs. If its assessment of the impact of US economic policies allows, the Fed will resume its cautious easing path in the second half of 2025.
There has been a disconnect between 10-year bond yields in the US and Germany since the start of the year. This has been driven by several events. Firstly, a huge fiscal spending plan was passed in the German parliament covering defence spending and infrastructure investment, followed by the announcement of increased defence spending at EU level. This pushed up the 10-year German bond yield and caused the US-German 10-year spread to narrow to about 140 basis points. Next, the announcement of so-called reciprocal tariffs by the US on 2 April, which triggered fears of higher inflation and less and/or later monetary policy easing by the Fed, led to a sharp rise in US 10-year bond yields. Later, the rise also gradually started to reflect a more general risk aversion towards US assets, which was also fuelled by fears about central bank independence. The higher general risk aversion towards the US has been reflected in the sizeable depreciation of the US dollar since April.
The Czech National Bank (CNB) cut its policy rate by 25 basis points in both February and May 2025, which brought it to its current level of 3.50%. Only one additional interest rate cut in the last quarter of 2025 is expected as elevated momentum in service inflation remains a source of concern for the CNB. We expect the Czech koruna to gradually appreciate against the euro towards the end of 2025.
The Hungarian central bank has kept its policy rate unchanged at 6.5% since late 2024. With the CPI hovering around – but still above – the 3% target, the National Bank of Hungary will be careful not to lower its policy rate too quickly. We expect just one 25 basis-point cut this year, followed by two rate cuts in 2026 (by 75 basis points in total), which would take the base rate to 5.50%. The forint has strengthened since the beginning of the year, albeit with bumps along the way, such as when reciprocal tariffs were announced on 2 April. We expect the currency to moderately depreciate from its current levels by the end of 2025.
| Agenda | Interim dividend of 1 euro: ex-coupon: 5 Nov.2025, record: 6 Nov.2025, payment 7 Nov.2025 3Q2025 results: 13 November 2025 4Q2025/FY2025 results: 12 February 2026 Other events: www.kbc.com / Investor Relations / Financial calendar |
|---|---|
| More information on the quarter under review |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
Condensed interim consolidated financial statements according to IFRS
2Q 2025 and 1H 2025
AC: Amortised Cost ALM: Asset Liability Management AT1: Additional tier-1 instruments BBA: Building block approach CSM: Contractual service margin ECL: Expected Credit Loss FV: Fair Value FVO: Fair Value Option (designated upon initial recognition at Fair Value through Profit or Loss) FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss GCA: Gross Carrying Amount HFT: Held For Trading IFIE: Insurance finance income and expense MFVPL: Mandatorily Measured at Fair Value through Profit or Loss (including HFT) OCI: Other Comprehensive Income OPEX: Operating expenses P&L: Income statement PAA: Premium allocation approach POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings UL: Unit linked VFA: Variable fee approach
| (in millions of EUR) | Note | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 2 930 | 2 748 | 1 509 | 1 421 | 1 379 |
| Interest income | 3.1 | 8 839 | 10 225 | 4 418 | 4 421 | 5 103 |
| Interest expense | 3.1 | -5 909 | -7 477 | -2 909 | -3 000 | -3 724 |
| Insurance revenues before reinsurance | 3.6 | 1 561 | 1 441 | 788 | 773 | 726 |
| Non-life | 3.6 | 1 316 | 1 211 | 667 | 648 | 613 |
| Life | 3.6 | 246 | 230 | 121 | 125 | 114 |
| Dividend income | 42 | 33 | 33 | 9 | 26 | |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
3.3 | - 79 | - 52 | - 34 | - 45 | 3 |
| Net result from financial instruments at fair value through profit or loss |
3.3 | 62 | 118 | 50 | 12 | 78 |
| Insurance finance income and expense (for insurance contracts issued) |
3.6 | - 141 | - 170 | - 83 | - 57 | - 75 |
| Net fee and commission income | 3.4 | 1 357 | 1 237 | 667 | 690 | 623 |
| Fee and commission income | 3.4 | 1 697 | 1 563 | 844 | 854 | 789 |
| Fee and commission expense | 3.4 | - 341 | - 326 | - 177 | - 164 | - 166 |
| Net other income | 3.5 | 143 | 109 | 77 | 67 | 51 |
| TOTAL INCOME | 5 955 | 5 516 | 3 041 | 2 915 | 2 809 | |
| Operating expenses (excluding opex allocated to insurance expenses) | 3.7 | -2 518 | -2 381 | -1 020 | -1 498 | - 950 |
| Total Opex without bank and insurance tax | 3.7 | -2 232 | -2 137 | -1 125 | -1 106 | -1 074 |
| Total bank and insurance tax | 3.7 | - 566 | - 521 | - 27 | - 539 | - 2 |
| Minus: Opex allocated to insurance service expenses | 3.7 | 280 | 276 | 132 | 148 | 126 |
| Insurance service expenses before reinsurance | 3.6 | -1 230 | -1 152 | - 608 | - 622 | - 590 |
| Of which insurance commissions paid | 3.6 | - 206 | - 181 | - 105 | - 102 | - 92 |
| Non-life | 3.6 | -1 084 | -1 003 | - 541 | - 543 | - 514 |
| Of which Non-life - Claim related expenses | 3.6 | - 679 | - 623 | - 342 | - 337 | - 331 |
| Life | 3.6 | - 146 | - 149 | - 67 | - 79 | - 76 |
| Net result from reinsurance contracts held | 3.6 | - 24 | - 41 | - 15 | - 9 | - 24 |
| Impairment | 3.9 | - 162 | - 101 | - 124 | - 38 | - 85 |
| on FA at amortised cost and at FVOCI | 3.9 | - 155 | - 88 | - 116 | - 38 | - 72 |
| on goodwill | 3.9 | 0 | 0 | 0 | 0 | 0 |
| other | 3.9 | - 8 | - 13 | - 8 | 0 | - 13 |
| Share in results of associated companies and joint ventures | 3.10 | 2 | 2 | 1 | 0 | 2 |
| RESULT BEFORE TAX | 2 022 | 1 842 | 1 275 | 747 | 1 162 | |
| Income tax expense | 3.11 | - 458 | - 412 | - 257 | - 202 | - 237 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| RESULT AFTER TAX | 1 564 | 1 431 | 1 018 | 546 | 925 | |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 1 564 | 1 431 | 1 018 | 546 | 925 | |
| Earnings per share (in EUR) | ||||||
| Ordinary | 3.82 | 3.44 | 2.50 | 1.32 | 2.25 | |
| Diluted | 3.82 | 3.44 | 2.50 | 1.32 | 2.25 |
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 1 564 | 1 431 | 1 018 | 546 | 925 |
| Attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 1 564 | 1 431 | 1 018 | 546 | 925 |
| OCI THAT MAY BE RECYCLED TO PROFIT OR LOSS | 715 | - 148 | 264 | 451 | 4 |
| Net change in revaluation reserve (FVOCI debt | |||||
| instruments) | 45 | - 235 | 156 | - 111 | - 136 |
| Fair value adjustments before tax | 62 | - 310 | 205 | - 142 | - 178 |
| Deferred tax on fair value changes | - 16 | 74 | - 50 | 34 | 41 |
| Transfer from reserve to net result | - 1 | 0 | 1 | - 2 | 2 |
| Impairment | 1 | 0 | 1 | 0 | 0 |
| Net gains/losses on disposal | - 2 | 0 | 0 | - 2 | 0 |
| Deferred taxes on income | 0 | 0 | 0 | 1 | 1 |
| Net change in hedging reserve (cashflow hedges) | 274 | 89 | 49 | 224 | 85 |
| Fair value adjustments before tax | 328 | 72 | 45 | 283 | 98 |
| Deferred tax on fair value changes | - 80 | - 18 | - 9 | - 71 | - 24 |
| Transfer from reserve to net result | 27 | 36 | 14 | 12 | 11 |
| Gross amount | 35 | 48 | 19 | 16 | 14 |
| Deferred taxes on income | - 9 | - 12 | - 5 | -4 | - 4 |
| Net change in translation differences | 82 | - 134 | 13 | 70 | 35 |
| Gross amount | 82 | - 134 | 13 | 70 | 35 |
| Deferred taxes on income | 0 | 0 | 0 | 0 | 0 |
| Hedge of net investments in foreign operations | 0 | 24 | 11 | - 11 | - 18 |
| Fair value adjustments before tax | - 5 | 39 | 11 | - 16 | - 15 |
| Deferred tax on fair value changes | 1 | - 10 | - 3 | 4 | 4 |
| Transfer from reserve to net result | 3 | - 6 | 3 | 0 | - 6 |
| Gross amount | 4 | - 8 | 4 | 0 | - 8 |
| Deferred taxes on income | - 1 | 2 | - 1 | 0 | 2 |
| Net insurance finance income and expense from (re)insurance contracts issued and held |
317 | 107 | 34 | 284 | 40 |
| Present value adjustments before tax | 424 | 141 | 45 | 379 | 52 |
| Deferred taxes on present value changes | - 107 | - 34 | - 11 | - 95 | - 13 |
| Transfer from reserve to net result (transfer/derecognition ) | 0 | 0 | 0 | 0 | 0 |
| Gross amount | 0 | 0 | 0 | 0 | 0 |
| Deferred taxes on income | 0 | 0 | 0 | 0 | 0 |
| Net change in respect of associated companies and joint | |||||
| ventures | 0 | 0 | 0 | 0 | 0 |
| Gross amount | 0 | 0 | 0 | 0 | 0 |
| Deferred taxes on income | 0 | 0 | 0 | 0 | 0 |
| Other movements | - 3 | 1 | 1 | - 5 | - 1 |
| OCI THAT WILL NOT BE RECYCLED TO PROFIT OR LOSS | - 87 | 188 | - 11 | - 76 | 36 |
| Net change in revaluation reserve (FVOCI equity | |||||
| instruments) Fair value adjustments before tax |
- 54 | 144 | - 4 | - 50 | 30 |
| Deferred tax on fair value changes | - 52 | 143 | - 4 | - 47 | 29 |
| Net change in defined benefit plans | - 2 | 1 | 0 | - 2 | 0 |
| Remeasurements | - 33 | 44 | - 7 | - 26 | 7 |
| Deferred tax on remeasurements | - 48 | 57 | - 9 | - 39 | 9 |
| 15 | - 13 | 2 | 13 | - 2 | |
| Net change in own credit risk | - 1 | 0 | - 1 | 0 | 0 |
| Fair value adjustments before tax | - 1 | 0 | - 1 | 0 | 0 |
| Deferred tax on fair value changes | 0 | 0 | 0 | 0 | 0 |
| Net change in respect of associated companies and joint ventures |
0 | 0 | 0 | 0 | 0 |
| Remeasurements | 0 | 0 | 0 | 0 | 0 |
| Deferred tax on remeasurements | 0 | 0 | 0 | 0 | 0 |
| TOTAL COMPREHENSIVE INCOME | 2 192 | 1 471 | 1 271 | 921 | 966 |
| Attributable to minority interests | 1 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 2 191 | 1 471 | 1 271 | 921 | 966 |
The largest movements in other comprehensive income (1H 2025 and 1H 2024):
| (in millions of EUR) | Note | 30-06-2025 | 31-12-2024 |
|---|---|---|---|
| ASSETS | |||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 36 039 | 46 834 | |
| Financial assets | 4.0 | 347 271 | 318 540 |
| Amortised cost | 4.0 | 291 393 | 265 875 |
| Fair value through OCI | 4.0 | 27 265 | 24 261 |
| Fair value through profit or loss | 4.0 | 28 385 | 28 132 |
| of which held for trading | 4.0 | 10 533 | 10 509 |
| Hedging derivatives | 4.0 | 228 | 271 |
| Reinsurers' contract assets held | 84 | 119 | |
| Accumulated profit/loss on positions in portfolios hedged for interest rate risk | -2 219 | -1 930 | |
| Tax assets | 919 | 1 002 | |
| Current tax assets | 88 | 59 | |
| Deferred tax assets | 831 | 942 | |
| Non-current assets held for sale and disposal groups | 1 | 1 | |
| Investments in associated companies and joint ventures | 59 | 116 | |
| Property, equipment and investment property | 4 024 | 3 981 | |
| Goodwill and other intangible assets | 2 558 | 2 475 | |
| Other assets | 1 933 | 1 911 | |
| TOTAL ASSETS | 390 669 | 373 048 | |
| LIABILITIES AND EQUITY | |||
| Financial liabilities | 4.0 | 344 094 | 328 723 |
| Amortised cost | 4.0 | 320 545 | 306 050 |
| Fair value through profit or loss | 4.0 | 23 241 | 22 356 |
| of which held for trading | 4.0 | 6 464 | 5 677 |
| Hedging derivatives | 4.0 | 308 | 316 |
| Insurance contract liabilities | 5.6 | 17 022 | 17 111 |
| Non-life | 5.6 | 3 280 | 3 186 |
| Life | 5.6 | 13 742 | 13 925 |
| Profit/loss on positions in portfolios hedged for interest rate risk | - 300 | - 386 | |
| Tax liabilities | 660 | 470 | |
| Current tax liabilities | 179 | 121 | |
| Deferred tax liabilities | 481 | 349 | |
| Liabilities associated with disposal groups | 0 | 0 | |
| Provisions for risks and charges | 140 | 141 | |
| Other liabilities | 2 825 | 2 678 | |
| TOTAL LIABILITIES | 364 440 | 348 737 | |
| Total equity | 5.10 | 26 229 | 24 311 |
| Parent shareholders' equity | 5.10 | 23 339 | 22 447 |
| Additional tier-1 instruments included in equity | 5.10 | 2 864 | 1 864 |
| Minority interests | 27 | 0 | |
| TOTAL LIABILITIES AND EQUITY | 390 669 | 373 048 |
| Issued | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| and paid up |
Total | Parent | AT1 instruments |
||||||
| (in millions of EUR) | share capital |
Share premium |
Treasury shares |
Retained earnings |
revaluation reserves |
shareholders' equity |
included in equity |
Minority interests |
Total equity |
| 30-06-2025 | |||||||||
| Balance at the beginning of the period | 1 462 | 5 564 | -1 300 | 15 724 | 997 | 22 447 | 1 864 | 0 | 24 311 |
| Net result for the period | 0 | 0 | 0 | 1 564 | 0 | 1 564 | 0 | 0 | 1 564 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 3 | 631 | 627 | 0 | 0 | 628 |
| Subtotal | 0 | 0 | 0 | 1 560 | 631 | 2 191 | 0 | 1 | 2 192 |
| Dividends | 0 | 0 | 0 | -1 249 | 0 | -1 249 | 0 | 0 | -1 249 |
| Coupon on AT1 | 0 | 0 | 0 | - 46 | 0 | - 46 | 0 | 0 | - 46 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | - 4 | 0 | - 4 | 1 000 | 0 | 996 |
| Capital increase | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 15 | - 15 | 0 | 0 | 0 | 0 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26 | 26 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total change | 0 | 0 | 0 | 276 | 616 | 892 | 1 000 | 26 | 1 918 |
| Balance at the end of the period | 1 462 | 5 564 | -1 300 | 15 999 | 1 614 | 23 339 | 2 864 | 27 | 26 229 |
| 2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Restatement related to previous year(s) | 0 | 0 | 0 | - 41 | 0 | - 41 | 0 | 0 | - 41 |
| Restated balance | 1 461 | 5 548 | - 497 | 14 290 | 1 166 | 21 968 | 2 250 | 0 | 24 219 |
| Net result for the period | 0 | 0 | 0 | 3 415 | 0 | 3 415 | 0 | - 1 | 3 414 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 2 | - 121 | - 123 | 0 | 0 | - 123 |
| Subtotal | 0 | 0 | 0 | 3 413 | - 121 | 3 292 | 0 | - 1 | 3 292 |
| Dividends | 0 | 0 | 0 | -1 942 | 0 | -1 942 | 0 | 0 | -1 942 |
| Coupon on AT1 | 0 | 0 | 0 | - 84 | 0 | - 84 | 0 | 0 | - 84 |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 | - 2 | 0 | - 2 | - 386 | 0 | - 388 |
| Capital increase | 1 | 16 | 0 | 0 | 0 | 17 | 0 | 0 | 17 |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | 47 | - 47 | 0 | 0 | 0 | 0 |
| Purchase/sale of treasury shares | 0 | 0 | - 803 | 0 | 0 | - 803 | 0 | 0 | - 803 |
| Change in scope | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in minorities interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Total change | 1 | 16 | - 803 | 1 433 | - 168 | 478 | - 386 | 0 | 93 |
| Balance at the end of the period | 1 462 | 5 564 | -1 300 | 15 724 | 997 | 22 447 | 1 864 | 0 | 24 311 |
| 30-06-2024 | |||||||||
| Balance at the beginning of the period | 1 461 | 5 548 | - 497 | 14 332 | 1 166 | 22 010 | 2 250 | 0 | 24 260 |
| Restatement related to previous year(s) | 0 | 0 | 0 - 41 |
0 | - 41 | 0 | 0 | - 41 | |
| Restated balance | 1 461 | 5 548 | - 497 | 14 290 | 1 166 | 21 968 | 2 250 | 0 | 24 219 |
| Net result for the period | 0 | 0 | 0 1 431 |
0 | 1 431 | 0 | 0 | 1 431 | |
| OCI for the period | 0 | 0 | 0 1 |
39 | 40 | 0 | 0 | 40 | |
| Subtotal | 0 | 0 | 0 1 432 |
39 | 1 471 | 0 | 0 | 1 471 | |
| Dividends | 0 | 0 | 0 -1 545 |
0 | -1 545 | 0 | 0 | -1 545 | |
| Coupon on AT1 | 0 | 0 | 0 - 47 |
0 | - 47 | 0 | 0 | - 47 | |
| Issue/repurchase of AT1 included in equity | 0 | 0 | 0 0 |
0 | 0 | - 500 | 0 | - 500 | |
| Capital increase | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 21 |
- 21 | 0 | 0 | 0 | 0 | |
| Purchase/sale of treasury shares | 0 | 0 | - 661 | 0 | 0 | - 661 | 0 | 0 | - 661 |
| Change in scope | 0 | 0 | 0 0 |
0 | 0 | 0 | 0 | 0 | |
| Change in minorities interests | 0 | 0 | 0 0 |
0 | 0 | 0 | 1 | 1 | |
| Total change | 0 | 0 | - 661 | - 140 | 18 | - 783 | - 500 | 0 | -1 282 |
| Balance at the end of the period | 1 461 | 5 548 | -1 158 | 14 151 | 1 184 | 21 185 | 1 750 | 1 | 22 936 |
For more information: https://www.kbc.com/en/share-buy-back and Solvency section further in this report.
| Composition of the 'Total revaluation reserves' column in the previous table (in millions of EUR) | 30-06-2025 | 31-12-2024 | 30-06-2024 |
|---|---|---|---|
| Total | 1 614 | 997 | 1 184 |
| Revaluation reserve (FVOCI debt instruments) | - 639 | - 684 | - 831 |
| Revaluation reserve (FVOCI equity instruments) | 285 | 353 | 345 |
| Hedging reserve (cashflow hedges) | - 234 | - 507 | - 490 |
| Translation differences | - 386 | - 468 | - 374 |
| Hedge of net investments in foreign operations | 168 | 169 | 150 |
| Remeasurement of defined benefit plans | 470 | 503 | 478 |
| Own credit risk through OCI | - 1 | 0 | 0 |
| Insurance finance income and expense through OCI after reinsurance | 1 950 | 1 633 | 1 906 |
| (in millions of EUR) | Note | 1H 2025 | 1H 2024 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Result before tax | Cons. income stat. |
2 022 | 1 842 |
| Adjustments for non-cash items in profit & loss | 284 | 1 157 | |
| Result before tax from discontinued operations | Consolidated income statement |
0 | 0 |
| Depreciation, impairment and amortisation of property, plant and equipment, intangible fixed assets, investment property and securities |
3.9 | 222 | 213 |
| Profit/Loss on the disposal of investments | — | - 36 | - 14 |
| Change in impairment on financial assets at AC | 3.9 | 154 | 88 |
| Change in insurance contract liabilities (before reinsurance) | - 190 | - 118 | |
| Change in reinsurance contract assets held | 24 | 41 | |
| Change in other provisions | - 7 | - 3 | |
| Other unrealised gains/losses | — | 119 | 952 |
| Income from associated companies and joint ventures | - 2 | - 2 | |
| Cashflows from operating profit before tax and before changes in operating assets and liabilities | — | 2 306 | 2 999 |
| Changes in operating assets (excluding cash and cash equivalents) | -13 422 | -9 961 | |
| Financial assets at amortised cost (excluding debt securities) | 4.1 | -10 867 | -5 330 |
| Financial assets at fair value through OCI | 4.1 | -2 921 | -1 311 |
| Financial assets at fair value through profit or loss | 4.1 | 373 | -3 073 |
| of which financial assets held for trading | 4.1 | 551 | -1 560 |
| Hedging derivatives | 4.1 | 44 | - 49 |
| Reinsurance assets | - 29 | - 53 | |
| Operating assets associated with disposal groups, and other assets | — | - 22 | - 146 |
| Changes in operating liabilities (excluding cash and cash equivalents) | 14 774 | 12 783 | |
| Financial liabilities at amortised cost | 4.1 | 12 964 | 12 482 |
| Financial liabilities at fair value through profit or loss | 4.1 | 904 | 78 |
| of which financial liabilities held for trading | 4.1 | 787 | -1 286 |
| Hedging derivatives | 4.1 | 319 | - 18 |
| Insurance contracts liabilities | 500 | 25 | |
| Operating liabilities associated with disposal groups and other liabilities |
— | 86 | 217 |
| Income taxes paid | - 362 | - 301 | |
| Net cash from or used in operating activities | 3 296 | 5 520 | |
| INVESTING ACTIVITIES | |||
| Purchase and proceeds of debt securities at amortised cost Acquisition of a subsidiary or a business unit, net of cash acquired (including increases in percentage |
4.1 | -1 832 | 2 623 |
| interest held) Proceeds from the disposal of a subsidiary or business unit, net of cash disposed of (including decreases in |
0 | 0 | |
| percentage interest held) | 40 | 0 | |
| Purchase of shares in associated companies and joint ventures | — | 1 | - 5 |
| Proceeds from the disposal of shares in associated companies and joint ventures | — | 0 | 0 |
| Dividends received from associated companies and joint ventures | — | 58 | 0 |
| Purchase and proceeds from the sale of investment property | 52 | - 89 | |
| Purchase and proceeds from the sale of intangible fixed assets (excluding goodwill) | - 159 | - 171 | |
| Purchase and proceeds from the sale of property, plant and equipment (excluding goodwill) | - 92 | - 70 | |
| Net cash from or used in investing activities | -1 932 | 2 289 | |
| FINANCING ACTIVITIES | |||
| Purchase or sale of treasury shares | Cons. stat. of changes in equity |
0 | - 661 |
| Issue or repayment of promissory notes and other debt securities | 4.1 | -1 507 | - 290 |
| Proceeds from or repayment of subordinated liabilities | 4.1 | - 171 | 1 609 |
| Proceeds from the issuance of share capital | Cons. stat. of changes in equity |
0 | 0 |
| Consolidated statement of |
|||
| Issue or call of additional tier-1 instruments | changes in equity | 996 | - 500 |
| Dividends paid | Cons. stat. of changes in equity |
-1 249 | -1 545 |
| Cons. stat. of | |||
| Coupon additional Tier-1 instruments Net cash from or used in financing activities |
changes in equity | - 46 -1 977 |
- 47 -1 435 |
| (in millions of EUR) | Note | 1H 2025 | 1H 2024 |
|---|---|---|---|
| CHANGE IN CASH AND CASH EQUIVALENTS | |||
| Net increase or decrease in cash and cash equivalents | - 614 | 6 374 | |
| Cash and cash equivalents at the beginning of the period | 61 407 | 53 961 | |
| Effects of exchange rate changes on opening cash and cash equivalents | 451 | - 365 | |
| Cash and cash equivalents at the end of the period | 61 244 | 59 970 | |
| ADDITIONAL INFORMATION | |||
| Interest paid | 3.1 | -5 909 | -7 477 |
| Interest received | 3.1 | 8 839 | 10 225 |
| Dividends received (including equity method) | 101 | 33 | |
| COMPONENTS OF CASH AND CASH EQUIVALENTS | |||
| Cash and cash balances with central banks and other demand deposits with credit institutions | Cons. balance sheet |
36 039 | 39 961 |
| Term loans to banks at not more than three months (excl. reverse repos) | 4.1 | 625 | 592 |
| Reverse repos with credit institutions at not more than three months | 4.1 | 32 804 | 28 647 |
| Deposits from banks repayable on demand | 4.1 | -8 223 | -9 230 |
| Cash and cash equivalents belonging to disposal groups | 0 | 0 | |
| Total | 61 244 | 59 970 | |
| of which not available | 0 | 0 |
The condensed interim financial statements of the KBC Group for the period ended 30 June 2025 have been prepared in accordance with IAS 34, 'Interim financial reporting' . The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2024, which have been prepared in accordance with the IFRS Accounting Standards as adopted by the European Union ('endorsed IFRS').
The following IFRS standards were issued but not yet effective in 2025. KBC will apply these standards when they become mandatory.
The IASB published several limited amendments to existing IFRSs and IFRICs. They will be applied when they become mandatory, but their impact is currently estimated to be negligible.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2024.
| Exchange rate at 30-06-2025 |
Average exchange rate in 1H 2025 | |||
|---|---|---|---|---|
| Changes relative to 31-12-2024 | Changes relative to the average 1H 2024 | |||
| 1 EUR = … | Positive: appreciation relative to EUR | 1 EUR = … | Positive: appreciation relative to EUR | |
| … currency | Negative: depreciation relative to EUR | … currency | Negative: depreciation relative to EUR | |
| CZK | 24.746 | 2% | 24.993 | 0% |
| HUF | 399.80 | 3% | 403.84 | -3% |
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2024.
| Belgium | Czech Republic |
International Markets |
Of | |||||
|---|---|---|---|---|---|---|---|---|
| Business | Business | Business | which: | Group | ||||
| (in millions of EUR) 1H 2025 |
unit | unit | unit | Hungary | Slovakia | Bulgaria | Centre | Total |
| Net interest income | 1 730 | 684 | 659 | 290 | 143 | 227 | - 143 | 2 930 |
| Insurance revenues before reinsurance | 941 | 321 | 292 | 109 | 57 | 127 | 7 | 1 561 |
| Non-life | 784 | 269 | 256 | 97 | 45 | 115 | 7 | 1 316 |
| Life | 157 | 53 | 36 | 12 | 12 | 12 | 0 | 246 |
| Dividend income | 41 | 0 | 0 | 0 | 0 | 0 | 2 | 42 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 164 | 42 | 26 | 19 | 8 | - 1 | 18 | - 79 |
| Net fee and commission income | 884 | 182 | 293 | 166 | 46 | 80 | - 1 | 1 357 |
| Net other income | 132 | 4 | 12 | 4 | 6 | 3 | - 5 | 143 |
| TOTAL INCOME | 3 564 | 1 234 | 1 283 | 588 | 260 | 435 | - 125 | 5 955 |
| Operating expenses (excluding opex allocated to insurance service expenses) |
-1 452 | - 429 | - 556 | - 297 | - 126 | - 133 | - 81 | -2 518 |
| Total Opex without banking and insurance tax | -1 255 | - 465 | - 433 | - 161 | - 135 | - 137 | - 78 | -2 232 |
| Total Banking and insurance tax | - 356 | - 21 | - 185 | - 166 | - 6 | - 14 | - 4 | - 566 |
| Minus: Opex allocated to insurance service expenses |
160 | 57 | 62 | 30 | 14 | 18 | 1 | 280 |
| Insurance service expenses before reinsurance | - 745 | - 246 | - 239 | - 95 | - 49 | - 95 | - 1 | -1 230 |
| Of which insurance commissions paid | - 127 | - 43 | - 36 | - 7 | - 7 | - 22 | 0 | - 206 |
| Non-Life | - 650 | - 218 | - 216 | - 89 | - 39 | - 88 | - 1 | -1 084 |
| Of which Non-life - Claim related expenses | - 437 | - 130 | - 113 | - 37 | - 24 | - 52 | 1 | - 679 |
| Life | - 95 | - 28 | - 23 | - 7 | - 9 | - 7 | 0 | - 146 |
| Net result from reinsurance contracts held | - 19 | - 3 | - 9 | - 2 | - 2 | - 4 | 8 | - 24 |
| Impairment | - 103 | - 26 | - 38 | - 8 | - 9 | - 21 | 4 | - 162 |
| of which on FA at AC and at fair value through OCI | - 101 | - 26 | - 32 | - 4 | - 8 | - 21 | 4 | - 155 |
| Share in results of associated companies and joint ventures | 3 | - 1 | 0 | 0 | 0 | 0 | 0 | 2 |
| RESULT BEFORE TAX | 1 248 | 528 | 441 | 184 | 74 | 183 | - 194 | 2 022 |
| Income tax expense | - 360 | - 81 | - 69 | - 28 | - 15 | - 27 | 52 | - 458 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 888 | 447 | 372 | 157 | 59 | 156 | - 143 | 1 564 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 888 | 447 | 372 | 157 | 59 | 156 | - 143 | 1 564 |
| Czech | International | |||||||
|---|---|---|---|---|---|---|---|---|
| Belgium | Republic | Markets | Of | |||||
| (in millions of EUR) | Business unit |
Business unit |
Business unit |
which: Hungary |
Slovakia | Bulgaria | Group Centre |
Total |
| 1H 2024 | ||||||||
| Net interest income | 1 640 | 639 | 641 | 287 | 137 | 217 | - 171 | 2 748 |
| Insurance revenues before reinsurance | 888 | 282 | 264 | 102 | 52 | 110 | 7 | 1 441 |
| Non-life | 736 | 233 | 235 | 92 | 42 | 100 | 7 | 1 211 |
| Life | 152 | 49 | 29 | 10 | 10 | 9 | 0 | 230 |
| Dividend income | 31 | 1 | 0 | 0 | 0 | 0 | 2 | 33 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for insurance contracts issued) |
- 165 | 33 | 40 | 35 | 6 | - 1 | 40 | - 52 |
| Net fee and commission income | 818 | 168 | 253 | 135 | 42 | 76 | - 2 | 1 237 |
| Net other income | 101 | 3 | 15 | 6 | 8 | 1 | - 10 | 109 |
| TOTAL INCOME | 3 313 | 1 125 | 1 212 | 565 | 245 | 402 | - 134 | 5 516 |
| Operating expenses (excluding opex allocated to insurance service expenses) |
-1 344 | - 425 | - 541 | - 266 | - 129 | - 145 | - 72 | -2 381 |
| Total Opex without banking and insurance tax | -1 215 | - 440 | - 408 | - 141 | - 126 | - 141 | - 74 | -2 137 |
| Total Banking and insurance tax | - 285 | - 38 | - 199 | - 161 | - 17 | - 21 | 1 | - 521 |
| Minus: Opex allocated to insurance service expenses |
156 | 54 | 66 | 36 | 13 | 17 | 1 | 276 |
| Insurance service expenses before reinsurance | - 704 | - 202 | - 246 | - 110 | - 56 | - 80 | 0 -1 152 | |
| Of which insurance commissions paid | - 117 | - 33 | - 32 | - 6 | - 6 | - 19 | 0 | - 181 |
| Non-Life | - 599 | - 177 | - 226 | - 103 | - 49 | - 75 | 0 | -1 003 |
| Of which Non-life - Claim related expenses | - 400 | - 102 | - 122 | - 45 | - 34 | - 43 | 1 | - 623 |
| Life | - 104 | - 25 | - 20 | - 7 | - 7 | - 6 | 0 | - 149 |
| Net result from reinsurance contracts held | - 33 | - 10 | - 3 | 3 | - 1 | - 6 | 4 | - 41 |
| Impairment | - 160 | 37 | 17 | 8 | 17 | - 7 | 5 | - 101 |
| of which on FA at AC and at fair value through OCI | - 159 | 38 | 28 | 18 | 17 | - 7 | 5 | - 88 |
| Share in results of associated companies and joint ventures | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| RESULT BEFORE TAX | 1 074 | 526 | 440 | 199 | 76 | 165 | - 197 | 1 842 |
| Income tax expense | - 313 | - 85 | - 70 | - 29 | - 16 | - 25 | 56 | - 412 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT AFTER TAX | 761 | 441 | 370 | 171 | 60 | 140 | - 141 | 1 431 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 761 | 441 | 370 | 171 | 60 | 140 | - 141 | 1 431 |
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total | 2 930 | 2 748 | 1 509 | 1 421 | 1 379 |
| Interest income | 8 839 | 10 225 | 4 418 | 4 421 | 5 103 |
| Interest income on financial instruments calculated using the effective interest rate method | |||||
| Financial assets at AC | 4 747 | 4 963 | 2 405 | 2 343 | 2 479 |
| Financial assets at FVOCI | 348 | 225 | 189 | 159 | 123 |
| Hedging derivatives | 2 588 | 3 112 | 1 283 | 1 305 | 1 553 |
| Financial liabilities (negative interest) | 1 | 4 | 1 | 1 | 2 |
| Other | 571 | 917 | 273 | 298 | 416 |
| Interest income on other financial instruments | |||||
| Financial assets MFVPL other than held for trading | 44 | 33 | 23 | 20 | 17 |
| Financial assets held for trading | 541 | 972 | 245 | 296 | 513 |
| Of which economic hedges | 438 | 879 | 192 | 246 | 464 |
| Other financial assets at FVPL | 0 | 0 | 0 | 0 | 0 |
| Interest expense | -5 909 | -7 477 | -2 909 | -3 000 | -3 724 |
| Interest expense on financial instruments calculated using the effective interest rate method |
|||||
| Financial liabilities at AC | -2 882 | -3 430 | -1 437 | -1 444 | -1 679 |
| Financial assets (negative interest) | - 1 | - 1 | 0 | - 1 | 0 |
| Hedging derivatives | -2 568 | -3 056 | -1 278 | -1 290 | -1 533 |
| Other | - 3 | - 2 | - 1 | - 1 | - 1 |
| Interest expense on other financial instruments | |||||
| Financial liabilities held for trading | - 441 | - 954 | - 184 | - 256 | - 495 |
| Of which economic hedges | - 421 | - 928 | - 174 | - 247 | - 483 |
| Other financial liabilities at FVPL | - 20 | - 36 | - 10 | - 10 | - 17 |
| Net interest expense relating to defined benefit plans | 4 | 2 | 2 | 2 | 1 |
The interest income on financial instruments calculated using the effective interest rate method – other, is mainly related to interest income on cash balances with central banks. These cash and cash balances are mainly funded with short term liabilities, such as certificates of deposit and repos. The interest expense related to this funding is part of interest expense on financial liabilities at AC. Net interest margin on this activity is narrow, resulting in limited net interest income.
The impact on net interest income of central banks' Minimum Reserve Requirements (MRR) (and their remuneration on these deposits) was about -44 million euros in 2Q 2025, compared to -43 million euros in 1Q 2025 and -51 million euros in 2Q 2024.
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total | - 79 | - 52 | - 34 | - 45 | 3 |
| Breakdown by driver | |||||
| Dealing room income | 137 | 164 | 60 | 77 | 62 |
| MTM ALM derivatives and other | - 81 | - 102 | - 27 | - 55 | 0 |
| Market value adjustments (xVA) | - 1 | 6 | 0 | - 1 | 1 |
| Result on investment backing UL contracts - under IFRS 17 & Insurance finance | |||||
| income and expense | - 133 | - 120 | - 67 | - 67 | - 60 |
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 2Q 2025 is 11 million euros less negative compared to 1Q 2025.
The quarter-on-quarter evolution is explained as follows:
Partly offset by
• Lower dealing room income in 2Q 2025 mainly in Belgium
The result from financial instruments at fair value through profit or loss and Insurance finance income and expenses in 1H 2025 is 27 million euros more negative compared to 1H 2024.
Partly compensated by
• Less negative MTM ALM derivatives and other income in 1H 2025 compared to 1H 2024
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total | 1 357 | 1 237 | 667 | 690 | 623 |
| Fee and commission income | 1 697 | 1 563 | 844 | 854 | 789 |
| Fee and commission expense | - 341 | - 326 | - 177 | - 164 | - 166 |
| Breakdown by type | |||||
| Asset Management Services | 743 | 683 | 364 | 379 | 344 |
| Fee and commission income | 765 | 713 | 374 | 391 | 360 |
| Fee and commission expense | - 23 | - 31 | - 11 | - 12 | - 16 |
| Banking Services | 589 | 527 | 291 | 298 | 267 |
| Fee and commission income | 904 | 820 | 456 | 448 | 416 |
| Fee and commission expense | - 315 | - 292 | - 165 | - 150 | - 149 |
| Other | 25 | 27 | 13 | 13 | 12 |
| Fee and commission income | 28 | 30 | 14 | 15 | 13 |
| Fee and commission expense | - 3 | - 3 | - 1 | - 2 | - 1 |
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total | 143 | 109 | 77 | 67 | 51 |
| of which gains or losses on | |||||
| Sale of financial assets measured at amortised cost | - 16 | - 19 | - 7 | - 9 | - 9 |
| Sale of debt securities at FVOCI | 2 | 0 | 0 | 2 | 0 |
| Repurchase of financial liabilities measured at amortised cost | 0 | 0 | 0 | 0 | 0 |
| of which other, including: | 158 | 128 | 84 | 74 | 60 |
| Income from operational leasing activities | 67 | 58 | 36 | 32 | 30 |
| Income from VAB Group | 28 | 22 | 14 | 14 | 9 |
In 1H 2025: special items:
• Net other income is higher than the normal run rate of 50 million euros per quarter both in 1Q and 2Q 2025 due mainly to higher-than-average gains on the sale of real estate.
In 1H 2024: no special items
The table below includes intragroup transactions between bank and insurance entities (the results for insurance contracts concluded between the group's bank and insurance entities, interest that insurance companies receive on their deposits with bank entities, distribution commissions intra-group…) in order to give a more accurate view of the profitability of the insurance business.
| of which life | |||||
|---|---|---|---|---|---|
| direct | |||||
| (in millions of EUR) | Life | participating (VFA) |
Non-life | Non technical |
Total |
| 1H 2025 | |||||
| Insurance service result | 100 | 7 | 236 | — | 335 |
| Insurance revenues before reinsurance | 246 | 14 | 1 321 | — | 1 567 |
| Insurance service expenses | - 146 | - 8 | - 1 085 | — | - 1 231 |
| Of which Non-life - Claim related expenses | — | — | - 680 | — | - 680 |
| Investment result and insurance finance income and expenses | 69 | 0 | 32 | 8 | 109 |
| Investment result | 185 | 7 | 56 | 8 | 250 |
| Net interest income | 166 | 0 | 54 | 4 | 224 |
| Dividend income | 13 | 0 | 2 | 3 | 18 |
| Net result from financial instruments at fair value through P&L | 5 | 7 | 0 | 1 | 6 |
| Net other income | 1 | 0 | 1 | 0 | 3 |
| Impairment | 0 | 0 | 0 | 0 | 0 |
| Total insurance finance income and expenses before reinsurance |
- 116 | - 7 | - 24 | — | - 141 |
| Interest accretion | - 109 | — | - 25 | — | - 134 |
| Effect of changes in financial assumptions and foreign exchange differences |
0 | 0 | 0 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 7 | - 7 | — | — | - 7 |
| Net insurance and investment result before reinsurance | 168 | 7 | 268 | 8 | 444 |
| Net result from reinsurance contracts held | - 1 | — | - 23 | — | - 24 |
| Premiums paid to the reinsurer | - 18 | — | - 52 | — | - 70 |
| Commissions received | 0 | — | 5 | — | 5 |
| Amounts recoverable from reinsurer | 17 | — | 26 | — | 42 |
| Total (ceded) reinsurance finance income and expense | 0 | — | 0 | — | - 1 |
| Net insurance and investment result after reinsurance | 167 | 7 | 245 | 8 | 420 |
| Non-directly attributable income and expenses | 14 | - 1 | - 28 | 10 | - 4 |
| Net fee and commission income | 41 | 0 | - 1 | 15 | 56 |
| Net other income | — | — | — | 45 | 45 |
| Operating expenses (incl. banking and insurance tax) | - 27 | - 1 | - 27 | - 49 | - 104 |
| Impairment - Other | 0 | 0 | 0 | - 1 | - 1 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 96 | - 96 |
| Result after tax | 181 | 6 | 217 | - 78 | 320 |
| Attributable to minority interest | — | — | — | — | 0 |
| Attributable to equity holders of the parent | — | — | — | — | 320 |
| of which life | |||||
|---|---|---|---|---|---|
| direct participating |
Non | ||||
| (in millions of EUR) | Life | (VFA) | Non-life | technical | Total |
| 1H 2024 | |||||
| Insurance service result | 81 | 5 | 212 | — | 293 |
| Insurance revenues before reinsurance | 230 | 12 | 1 216 | — | 1 446 |
| Insurance service expenses | - 149 | - 7 | - 1 004 | — | - 1 153 |
| Of which Non-life - Claim related expenses | — | — | - 624 | — | - 624 |
| Investment result and insurance finance income and expenses | 80 | 2 | 27 | 3 | 110 |
| Investment result on assets | 228 | 50 | 49 | 3 | 280 |
| Net interest income | 161 | 0 | 44 | 0 | 205 |
| Dividend income | 14 | 0 | 2 | 3 | 19 |
| Net result from financial instruments at fair value through P&L | 51 | 50 | 0 | 0 | 52 |
| Net other income | 2 | 0 | 1 | 1 | 4 |
| Impairment | 1 | 0 | 0 | 0 | 1 |
| Total insurance finance income and expenses | |||||
| before reinsurance | - 149 | - 49 | - 21 | — | - 170 |
| Interest accretion Effect of changes in financial assumptions and foreign exchange |
- 100 | — | - 22 | — | - 121 |
| differences | - 1 | 0 | 1 | — | 0 |
| Changes in fair value re. liabilities of IFRS 17 unit linked contracts | - 49 | - 49 | — | — | - 49 |
| Net insurance and investment result before reinsurance | 161 | 7 | 239 | 3 | 403 |
| Net result from reinsurance contracts held | - 3 | — | - 38 | — | - 41 |
| Premiums paid to the reinsurer | - 19 | — | - 57 | — | - 76 |
| Commissions received | 4 | — | 5 | — | 9 |
| Amounts recoverable from reinsurer | 12 | — | 15 | — | 27 |
| Total (ceded) reinsurance finance income and expenses | 0 | — | - 1 | — | - 1 |
| Net insurance and investment result after reinsurance | 157 | 7 | 201 | 3 | 361 |
| Non-directly attributable income and expenses | 11 | - 1 | - 25 | 8 | - 6 |
| Net fee and commission income | 37 | 0 | - 1 | 17 | 53 |
| Net other income | — | — | — | 36 | 36 |
| Operating expenses (incl. banking and insurance tax) | - 26 | - 1 | - 24 | - 45 | - 95 |
| Impairment - Other | 0 | 0 | 0 | 0 | 0 |
| Share in results of assoc. comp & joint-ventures | — | — | — | 0 | 0 |
| Income tax | — | — | — | - 83 | - 83 |
| Result after tax | 168 | 6 | 176 | - 72 | 272 |
| Attributable to minority interest | — | — | — | — | 0 |
| Attributable to equity holders of the parent | — | — | — | — | 272 |
The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
The column 'of which life direct participating (VFA)' relates to results of long-term unit-linked contracts in Central and Eastern Europe.
Total insurance finance income and expenses before reinsurance includes changes in fair value of underlying assets of contracts measured under VFA, which represents the fair value movement of unit-linked liabilities, valued under IFRS 17 (variable fee approach), with the offsetting impact in fair value movement of underlying unit-linked assets in net result from financial instruments at fair value through profit or loss (see also note 3.3, result on investment backing UL contracts - under IFRS 17).
Amounts recoverable from reinsurer for Life also contains profit sharing (if any).
The total Operating expenses by nature include also Opex allocated to insurance service expenses (directly attributable from insurance) in order to provide a comprehensive overview of the total cost evolution.
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total Operating expenses by nature | -2 798 | -2 658 | -1 152 | -1 646 | -1 076 |
| Staff Expenses | -1 394 | -1 342 | - 704 | - 690 | - 679 |
| General administrative expenses | -1 206 | -1 131 | - 349 | - 857 | - 305 |
| ICT Expenses | - 316 | - 296 | - 162 | - 154 | - 151 |
| Facility Expenses | - 120 | - 119 | - 60 | - 60 | - 59 |
| Marketing & communication expenses | - 42 | - 42 | - 24 | - 18 | - 23 |
| Professional fees | - 65 | - 65 | - 34 | - 31 | - 33 |
| Bank and insurance tax | - 566 | - 521 | - 27 | - 539 | - 2 |
| Other | - 98 | - 88 | - 43 | - 55 | - 36 |
| Depreciation and amortisation of fixed assets | - 198 | - 185 | - 99 | - 99 | - 93 |
| (in millions of EUR) | 1H 2025 | 1H 2024 | 2Q 2025 | 1Q 2025 | 2Q 2024 |
|---|---|---|---|---|---|
| Total | - 162 | - 101 | - 124 | - 38 | - 85 |
| Impairment on financial assets at AC and at FVOCI | - 155 | - 88 | - 116 | - 38 | - 72 |
| By IFRS category | |||||
| Impairment on financial assets at AC | - 154 | - 88 | - 116 | - 38 | - 72 |
| Impairment on financial assets at FVOCI | - 1 | 0 | - 1 | 0 | 0 |
| By product | |||||
| Loans and advances | - 149 | - 89 | - 108 | - 41 | - 73 |
| Debt securities | - 2 | 0 | - 2 | 0 | 1 |
| Off-balance-sheet commitments and financial guarantees | - 4 | 1 | - 7 | 3 | 1 |
| By type | |||||
| Stage 1 (12-month ECL) | - 33 | - 13 | - 28 | - 5 | 23 |
| Stage 2 (lifetime ECL) | 7 | 51 | - 39 | 46 | - 44 |
| Stage 3 (non-performing; lifetime ECL) | - 111 | - 102 | - 49 | - 62 | - 48 |
| Purchased or originated credit impaired assets | - 19 | - 25 | - 1 | - 18 | - 2 |
| By division/country | |||||
| Belgium | - 101 | - 159 | - 77 | - 24 | - 122 |
| Czech Republic | - 26 | 38 | - 12 | - 14 | 41 |
| International Markets | - 32 | 28 | - 28 | - 4 | 9 |
| Slovakia | - 8 | 17 | - 10 | 2 | 6 |
| Hungary | - 4 | 18 | - 3 | 0 | 8 |
| Bulgaria | - 21 | - 7 | - 15 | - 6 | - 5 |
| Group Centre | 4 | 5 | 1 | 3 | 1 |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | - 8 | - 13 | - 8 | 0 | - 13 |
| Intangible fixed assets (other than goodwill) | - 2 | - 8 | - 2 | 0 | - 8 |
| Property, plant and equipment (including investment property) | 0 | 0 | 0 | 0 | 0 |
| Associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| Other | - 6 | - 5 | - 6 | 0 | - 5 |
The outstanding balance of ECL for the geopolitical and macroeconomic uncertainties amounts to 112 million euros at the end of 2Q 2025. As a reminder, this is determined based on individual counterparties and sectors deemed to have incurred an increase in credit risk because they are either exposed to macroeconomic risks (e.g. high(er) inflation, high(er) interest rates, high(er) energy prices, …) or indirectly exposed to military conflicts, such as the one in Ukraine.
| Meas | |||||||
|---|---|---|---|---|---|---|---|
| ured at | |||||||
| fair value through |
Mandatorily measured at |
||||||
| Meas | other | fair value | |||||
| ured at | compre | through profit | Desig | ||||
| amor | hensive | or loss | Held for | nated at | Hedging | ||
| tised | income | (MFVPL) excl. | trading | fair value | deriva | ||
| (in millions of EUR) | cost (AC) | (FVOCI) | HFT | (HFT) | (FVO) | tives | Total |
| FINANCIAL ASSETS, 30-06-2025 | |||||||
| Loans and advances to credit institutions (excl. reverse repos) |
2 897 | 0 | 0 | 1 | 0 | 0 | 2 897 |
| of which repayable on demand and term loans at not more than three months |
625 | ||||||
| Loans and advances to customers (excl. reverse repos) | 200 962 | 0 | 1 068 | 0 | 0 | 0 | 202 031 |
| Trade receivables | 2 901 | 0 | 0 | 0 | 0 | 0 | 2 901 |
| Consumer credit | 6 905 | 0 | 710 | 0 | 0 | 0 | 7 615 |
| Mortgage loans | 80 751 | 0 | 358 | 0 | 0 | 0 | 81 109 |
| Term loans | 95 820 | 0 | 0 | 0 | 0 | 0 | 95 820 |
| Finance lease | 8 108 | 0 | 0 | 0 | 0 | 0 | 8 108 |
| Current account advances | 5 573 | 0 | 0 | 0 | 0 | 0 | 5 573 |
| Other | 905 | 0 | 0 | 0 | 0 | 0 | 905 |
| Reverse repos | 34 259 | 0 | 0 | 575 | 0 | 0 | 34 834 |
| with credit institutions | 33 245 | 0 | 0 | 575 | 0 | 0 | 33 820 |
| with customers | 1 014 | 0 | 0 | 0 | 0 | 0 | 1 014 |
| Equity instruments | 0 | 1 692 | 10 | 983 | 0 | 0 | 2 684 |
| Unit linked investments (insurance) | 0 | 0 | 16 692 | 0 | 0 | 0 | 16 692 |
| Debt securities issued by | 52 185 | 25 573 | 82 | 4 966 | 0 | 0 | 82 806 |
| Public bodies | 44 798 | 21 252 | 0 | 3 506 | 0 | 0 | 69 556 |
| Credit institutions | 5 397 | 2 566 | 0 | 1 413 | 0 | 0 | 9 376 |
| Corporates | 1 991 | 1 755 | 82 | 46 | 0 | 0 | 3 874 |
| Derivatives | 0 | 0 | 0 | 4 009 | 0 | 228 | 4 237 |
| Other | 1 089 | 0 | 0 | 0 | 0 | 0 | 1 089 |
| Total | 291 393 | 27 265 | 17 852 | 10 533 | 0 | 228 | 347 271 |
| FINANCIAL ASSETS, 31-12-2024 | |||||||
| Loans and advances to credit institutions (excl. reverse repos) |
2 438 | 0 | 0 | 1 | 0 | 0 | 2 439 |
| of which repayable on demand and term loans at not more than three months |
225 | ||||||
| Loans and advances to customers (excl. reverse repos) | 191 124 | 0 | 943 | 0 | 0 | 0 | 192 067 |
| Trade receivables | 2 887 | 0 | 0 | 0 | 0 | 0 | 2 887 |
| Consumer credit | 6 316 | 0 | 633 | 0 | 0 | 0 | 6 949 |
| Mortgage loans | 77 750 | 0 | 309 | 0 | 0 | 0 | 78 059 |
| Term loans | 90 754 | 0 | 1 | 0 | 0 | 0 | 90 755 |
| Finance lease | 7 919 | 0 | 0 | 0 | 0 | 0 | 7 919 |
| Current account advances | 4 790 | 0 | 0 | 0 | 0 | 0 | 4 790 |
| Other | 708 | 0 | 0 | 0 | 0 | 0 | 708 |
| Reverse repos | 21 083 | 0 | 0 | 0 | 0 | 0 | 21 083 |
| with credit institutions | 20 922 | 0 | 0 | 0 | 0 | 0 | 20 922 |
| with customers | 162 | 0 | 0 | 0 | 0 | 0 | 162 |
| Equity instruments | 0 | 1 722 | 10 | 902 | 0 | 0 | 2 633 |
| Unit linked investments (insurance) | 0 | 0 | 16 602 | 0 | 0 | 0 | 16 602 |
| Debt securities issued by | 50 075 | 22 539 | 70 | 5 021 | 0 | 0 | 77 705 |
| Public bodies | 41 955 | 18 165 | 0 | 3 360 | 0 | 0 | 63 480 |
| Credit institutions | 5 982 | 2 510 | 0 | 1 593 | 0 | 0 | 10 085 |
| Corporates | 2 139 | 1 864 | 70 | 68 | 0 | 0 | 4 140 |
| Derivatives | 0 | 0 | 0 | 4 584 | 0 | 271 | 4 856 |
| Other | 1 154 | 0 | 0 | 0 | 0 | 0 | 1 154 |
| Total | 265 875 | 24 261 | 17 624 | 10 509 | 0 | 271 | 318 540 |
| Measured at | Held for | ||||
|---|---|---|---|---|---|
| (in millions of EUR) | amortised cost (AC) |
trading (HFT) |
Designated at fair value (FVO) |
Hedging derivatives |
Total |
| FINANCIAL LIABILITIES, 30-06-2025 | |||||
| Deposits from credit institutions (excl. repos) | 14 380 | 0 | 0 | 0 | 14 380 |
| of which repayable on demand | 8 223 | ||||
| Deposits from customers and debt securities (excl. | |||||
| repos) | 283 788 | 27 | 1 047 | 0 | 284 861 |
| Demand deposits | 115 885 | 0 | 0 | 0 | 115 885 |
| Time deposits | 39 084 | 27 | 208 | 0 | 39 319 |
| Savings accounts | 80 164 | 0 | 0 | 0 | 80 164 |
| Savings certificates | 1 258 | 0 | 0 | 0 | 1 258 |
| Subtotal, customer deposits | 236 391 | 27 | 208 | 0 | 236 626 |
| Certificates of deposit | 21 821 | 0 | 6 | 0 | 21 827 |
| Non-convertible bonds | 22 719 | 0 | 834 | 0 | 23 552 |
| Non-convertible subordinated liabilities | 2 857 | 0 | 0 | 0 | 2 857 |
| Repos | 19 949 | 165 | 0 | 0 | 20 114 |
| with credit institutions | 13 482 | 42 | 0 | 0 | 13 524 |
| with customers | 6 468 | 123 | 0 | 0 | 6 590 |
| Liabilities under investment contracts | 27 | 0 | 15 730 | 0 | 15 757 |
| Derivatives | 0 | 5 383 | 0 | 308 | 5 691 |
| Short positions | 0 | 889 | 0 | 0 | 889 |
| In equity instruments | 0 | 7 | 0 | 0 | 7 |
| In debt securities | 0 | 882 | 0 | 0 | 882 |
| Other | 2 401 | 0 | 0 | 0 | 2 401 |
| Total | 320 545 | 6 464 | 16 777 | 308 | 344 094 |
| FINANCIAL LIABILITIES, 31-12-2024 | |||||
| Deposits from credit institutions (excl. repos) | 12 852 | 0 | 0 | 0 | 12 852 |
| of which repayable on demand | 6 456 | ||||
| Deposits from customers and debt securities (excl. | 270 030 | 22 | 1 035 | 0 | 271 087 |
| repos) | |||||
| Demand deposits | 110 090 | 0 | 0 | 0 | 110 090 |
| Time deposits | 42 781 | 22 | 163 | 0 | 42 966 |
| Savings accounts | 74 440 | 0 | 0 | 0 | 74 440 |
| Savings certificates | 1 250 | 0 | 0 | 0 | 1 250 |
| Subtotal, customer deposits | 228 562 | 22 | 163 | 0 | 228 747 |
| Certificates of deposit | 14 376 | 0 | 5 | 0 | 14 382 |
| Non-convertible bonds | 24 185 | 0 | 745 | 0 | 24 930 |
| Non-convertible subordinated liabilities | 2 907 | 0 | 121 | 0 | 3 028 |
| Repos | 20 985 | 94 | 0 | 0 | 21 079 |
| with credit institutions | 18 587 | 94 | 0 | 0 | 18 681 |
| with customers | 2 398 | 0 | 0 | 0 | 2 398 |
| Liabilities under investment contracts | 27 | 0 | 15 644 | 0 | 15 671 |
| Derivatives | 0 | 4 679 | 0 | 316 | 4 995 |
| Short positions | 0 | 882 | 0 | 0 | 882 |
| In equity instruments | 0 | 9 | 0 | 0 | 9 |
| In debt securities | 0 | 872 | 0 | 0 | 872 |
| Other | 2 157 | 0 | 0 | 0 | 2 157 |
| Total | 306 050 | 5 677 | 16 680 | 316 | 328 723 |
| (in millions of EUR) | Carrying value before impairment |
Impairment | Carrying value after impairment |
|---|---|---|---|
| 30-06-2025 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 240 598 | - 2 480 | 238 118 |
| Stage 1 (12-month ECL) | 219 912 | - 198 | 219 714 |
| Stage 2 (lifetime ECL) | 16 858 | - 323 | 16 534 |
| Stage 3 (lifetime ECL) | 3 284 | - 1 803 | 1 482 |
| Purchased or originated credit impaired assets (POCI) | 544 | - 156 | 388 |
| Debt Securities | 52 195 | - 10 | 52 185 |
| Stage 1 (12-month ECL) | 52 114 | - 7 | 52 107 |
| Stage 2 (lifetime ECL) | 76 | - 1 | 76 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 25 578 | - 5 | 25 573 |
| Stage 1 (12-month ECL) | 25 563 | - 5 | 25 558 |
| Stage 2 (lifetime ECL) | 15 | 0 | 15 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| 31-12-2024 | |||
| FINANCIAL ASSETS AT AMORTISED COST | |||
| Loans and advances * | 217 093 | - 2 448 | 214 645 |
| Stage 1 (12-month ECL) | 197 031 | - 176 | 196 855 |
| Stage 2 (lifetime ECL) | 16 177 | - 331 | 15 847 |
| Stage 3 (lifetime ECL) | 3 472 | - 1 803 | 1 669 |
| Purchased or originated credit impaired assets (POCI) | 414 | - 138 | 276 |
| Debt Securities | 50 084 | - 8 | 50 075 |
| Stage 1 (12-month ECL) | 49 979 | - 6 | 49 973 |
| Stage 2 (lifetime ECL) | 100 | - 1 | 99 |
| Stage 3 (lifetime ECL) | 5 | - 2 | 3 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | |||
| Debt Securities | 22 543 | - 4 | 22 539 |
| Stage 1 (12-month ECL) | 22 543 | - 4 | 22 539 |
| Stage 2 (lifetime ECL) | 0 | 0 | 0 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 |
| Purchased or originated credit impaired assets (POCI) | 0 | 0 | 0 |
(*) The carrying value after impairment in this note is equal to the sum of the lines Loans and advances to credit institutions (excl. reverse repos), Loans and advances to customers (excl. reverse repos) and Reverse repos in note 4.1 (in the column Measured at amortised cost)
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2024.
| (in millions of EUR) | 30-06-2025 | 31-12-2024 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
16 623 | 82 | 1 147 | 17 852 | 16 539 | 75 | 1 009 | 17 624 | ||
| Held for trading | 3 722 | 5 780 | 1 032 | 10 533 | 3 354 | 6 097 | 1 057 | 10 509 | ||
| Designated at fair value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| At fair value through OCI | 24 585 | 2 019 | 661 | 27 265 | 21 410 | 2 200 | 651 | 24 261 | ||
| Hedging derivatives | 0 | 228 | 0 | 228 | 0 | 271 | 0 | 271 | ||
| Total | 44 930 | 8 109 | 2 840 | 55 878 | 41 303 | 8 644 | 2 717 | 52 665 | ||
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||||
| Held for trading | 890 | 4 069 | 1 505 | 6 464 | 883 | 3 388 | 1 406 | 5 677 | ||
| Designated at fair value | 15 730 | 251 | 795 | 16 777 | 15 644 | 186 | 850 | 16 680 | ||
| Hedging derivatives | 0 | 260 | 47 | 308 | 0 | 265 | 51 | 316 | ||
| Total | 16 620 | 4 581 | 2 347 | 23 549 | 16 527 | 3 838 | 2 307 | 22 673 |
During 1H 2025, KBC transferred about 525 million euros worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 382 million euros worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to a change in the liquidity of government and corporate bonds.
In 1H 2025 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
The Contractual Service Margin (CSM) as included in the insurance contract liabilities, evolved from 2 276 million euros at the end of 2024 to 2 334 million euros at 30 June 2025, or an increase of 58 million euros. This increase is mainly explained by CSM of new business (+119 million euros) which was higher compared to the CSM release in the income statement (-82 million euros), reinforced by positive interest accretion (time value) on the CSM (+13 million euros).
| Quantities | 30-06-2025 | 31-12-2024 |
|---|---|---|
| Ordinary shares | 417 544 151 | 417 544 151 |
| of which ordinary shares that entitle the holder to a dividend payment | 396 563 328 | 396 563 328 |
| of which treasury shares | 20 980 825 | 20 980 825 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | 0 | 0 |
For more information, please refer to a separate press release and investor presentation on our website www.kbc.com, published on 15 May 2025. No new information is available as of this date, awaiting the closing of the transaction.
Significant non-adjusting events between the balance sheet date (30 June 2025) and the publication of this report (7 August 2025):
• In line with our general dividend policy, the Board of Directors decided on the 6th of August 2025 to pay out an interim dividend of 1 euro per share in November 2025 as an advance on the total dividend for financial year 2025.

KBC Group I Quarterly Report – 2Q 2025 I p.37
Additional Information
2Q 2025 and 1H 2025
The main source of credit risk is the loan portfolio of the bank. It includes all the loans and guarantees that KBC has granted to individuals, companies, governments and banks. Debt securities in the investment portfolio are included if they are issued by companies or banks. Government bonds are not included. The loan portfolio as defined in this section differs from 'Loans and advances to customers' in Note 4.1 of the 'Consolidated financial statements' section of the annual accounts 2024. For more information, please refer to 'Details of ratios and terms on KBC Group level'.
A snapshot of the banking portfolio is shown in the table below. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit.
| Credit risk: loan portfolio overview | 30-06-2025 | 31-12-2024 |
|---|---|---|
| Total loan portfolio (in billions of EUR)1 | ||
| Amount outstanding and undrawn | 271 | 263 |
| Amount outstanding | 221 | 211 |
| Loan portfolio breakdown by business unit (as a % of the outstanding portfolio) | ||
| Belgium | 63.8% | 64.5% |
| Czech Republic | 20.0% | 19.4% |
| International Markets | 15.7% | 15.6% |
| Group Centre 2 | 0.4% | 0.5% |
| Loan portfolio breakdown by counterparty sector (as a % of the outstanding portfolio) | ||
| Private individuals | 40.6% | 40.8% |
| Finance and insurance | 5.4% | 5.3% |
| Governments | 3.4% | 2.9% |
| Corporates | 50.5% | 51.0% |
| Services | 10.6% | 10.7% |
| Distribution | 7.9% | 8.2% |
| Real estate 3 | 6.8% | 6.9% |
| Building & construction | 4.8% | 4.8% |
| Agriculture, farming, fishing | 2.7% | 2.7% |
| Automotive | 2.6% | 2.7% |
| Electricity | 2.1% | 1.9% |
| Food Producers | 1.8% | 2.0% |
| Metals | 1.6% | 1.5% |
| Chemicals | 1.3% | 1.4% |
| Shipping | 1.0% | 0.8% |
| Machinery & Heavy equipment | 0.9% | 0.9% |
| Oil, gas & other fuels | 0.9% | 0.9% |
| Hotels, bars & restaurants | 0.8% | 0.7% |
| Electrotechnics | 0.6% | 0.5% |
| Other 4 | 4.1% | 4.2% |
| Loan portfolio breakdown by region (as a % of the outstanding portfolio) | ||
| Belgium | 54.5% | 54.9% |
| Czech Republic | 18.8% | 18.6% |
| Slovakia | 6.2% | 6.1% |
| Hungary | 4.1% | 4.0% |
| Bulgaria | 5.7% | 5.6% |
| Rest of Western Europe | 7.4% | 7.6% |
| Rest of Central and Eastern Europe | 0.2% | 0.2% |
| North America | 1.0% | 1.1% |
| Asia | 0.8% | 0.9% |
| Other | 1.5% | 1.0% |
| Loan portfolio breakdown by counterparty (as % of the outstanding portfolio) | ||
| Retail | 40.5% | 40.7% |
| of which: mortgages | 36.5% | 36.8% |
| of which: consumer finance | 3.9% | 3.9% |
| SME | 21.7% | 22.0% |
| Corporate | 37.8% | 37.3% |
| 30-06-2025 | 31-12-2024 | |
|---|---|---|
| Loan portfolio breakdown by IFRS 9 ECL stage (as % of the outstanding portfolio) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 90.2% | 90.2% |
| of which: PD 1 - 4 | 64.2% | 64.5% |
| of which: PD 5 - 9 including unrated | 26.1% | 25.7% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 5 | 7.9% | 7.8% |
| of which: PD 1 - 4 | 2.3% | 2.2% |
| of which: PD 5 - 9 including unrated | 5.7% | 5.6% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 5 | 1.8% | 2.0% |
| of which: PD 10 impaired loans | 0.8% | 0.9% |
| of which: more than 90 days past due (PD 11+12) | 1.0% | 1.0% |
| Impaired loan portfolio (in millions of EUR) | ||
| Impaired loans (PD10 + 11 + 12) | 4 041 | 4 171 |
| of which: more than 90 days past due | 2 173 | 2 178 |
| Impaired loans ratio (%) | ||
| Belgium | 1.9% | 2.0% |
| Czech Republic | 1.3% | 1.3% |
| International Markets | 1.5% | 1.6% |
| Group Centre 2 | 36.0% | 38.3% |
| Total | 1.8% | 2.0% |
| of which: more than 90 days past due | 1.0% | 1.0% |
| Loan loss impairment (in millions of EUR) | ||
| Loan loss Impairment for Stage 1 portfolio | 230 | 201 |
| Loan loss Impairment for Stage 2 portfolio | 333 | 340 |
| Loan loss Impairment for Stage 3 portfolio | 1 991 | 1 979 |
| of which: more than 90 days past due | 1 496 | 1 492 |
| Cover ratio of impaired loans (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans | 49.3% | 47.4% |
| of which: more than 90 days past due | 68.8% | 68.5% |
| Cover ratio of impaired loans, mortgage loans excluded (%) | ||
| Loan loss impairments for stage 3 portfolio / impaired loans, mortgage loans excluded | 52.6% | 50.5% |
| of which: more than 90 days past due | 71.6% | 71.4% |
| Credit cost ratio (%) | ||
| Belgium | 0.14% | 0.19% |
| Czech Republic | 0.12% | -0.09% |
| International Markets | 0.19% | -0.08% |
| Slovakia | 0.12% | -0.14% |
| Hungary | 0.09% | -0.27% |
| Bulgaria | 0.33% | 0.14% |
| Group Centre | -0.04% | 1.58% |
| Total | 0.15% | 0.10% |
1 Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured in Gross
Carrying Amounts 2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group, activities in wind-down (e.g. ex-Antwerp Diamond Bank). The presence of the residual portfolios of the
activities in wind-down explains the high share of impaired loans 3 Real estate = Income producing commercial real estate to 3rd parties 4 Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
5 Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2024 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
| Loan portfolio per Business Unit | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-06-2025, in millions of EUR | Business Unit Belgium1 | Business Unit Czech Republic | Business Unit International Markets | Business Unit Group Centre2 | ||||||||
| Total portfolio outstanding | 141 064 | 44 229 | 34 797 | 872 | ||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | ||||||||
| retail | 48 464 | 34% | 24 691 | 56% | 16 257 | 47% | 0 | 0% | ||||
| o/w mortgages | 46 745 | 33% | 21 541 | 49% | 12 474 | 36% | 0 | 0% | ||||
| o/w consumer finance | 1 719 | 1% | 3 150 | 7% | 3 782 | 11% | 0 | 0% | ||||
| SME | 37 394 | 27% | 6 284 | 14% | 4 357 | 13% | 0 | 0% | ||||
| corporate | 55 207 | 39% | 13 253 | 30% | 14 184 | 41% | 872 | 100% | ||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | ||||
| total | 46 745 | 33% | 54% | 21 541 | 49% | 52% | 12 474 | 36% | 58% | 0 | 0% | 0% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | - | 61 | 0% | 37% | 0 | 0% | - |
| o/w ind. LTV > 100% | 421 | 0% | - | 13 | 0% | - | 69 | 0% | - | 0 | 0% | - |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | ||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 103 122 | 73% | 25 418 | 57% | 17 670 | 51% | 529 | 61% | ||||
| medium risk (PD 5-7; 0.80%-6.40%) | 31 729 | 22% | 16 170 | 37% | 15 418 | 44% | 29 | 3% | ||||
| high risk (PD 8-9; 6.40%-100.00%) | 3 320 | 2% | 2 053 | 5% | 1 164 | 3% | 0 | 0% | ||||
| impaired loans (PD 10 - 12) | 2 621 | 2% | 585 | 1% | 522 | 1% | 314 | 36% | ||||
| unrated | 272 | 0% | 4 | 0% | 23 | 0% | 0 | 0% | ||||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | ||||
| outstanding impaired loans | 2 621 | 1 190 | 45% | 585 | 252 | 43% | 522 | 247 | 47% | 314 | 302 | 96% |
| o/w PD 10 impaired loans | 1 367 | 372 | 27% | 241 | 50 | 21% | 242 | 67 | 28% | 18 | 7 | 38% |
| o/w more than 90 days past due (PD 11+12) | 1 254 | 818 | 65% | 344 | 203 | 59% | 280 | 180 | 64% | 295 | 295 | 100% |
| all impairments (stage 1+2+3) | 1 448 | 407 | 392 | 308 | ||||||||
| o/w stage 1+2 impairments (incl. POCI) | 258 | 154 | 145 | 6 | ||||||||
| o/w stage 3 impairments (incl. POCI) | 1 190 | 252 | 247 | 302 | ||||||||
| 2024 Credit cost ratio (CCR)3 | 0.19% | -0.09% | -0.08% | 1.58% | ||||||||
| 2025 Credit cost ratio (CCR)3 - YTD |
0.14% | 0.12% | 0.19% | -0.04% |
1 Business Unit Belgium = KBC Bank (all retail and corporate credit lending activities including the foreign branches, part of non-legacy portfolio assigned to BU Belgium), CBC, KBC Lease Belgium,
KBC Immolease, KBC Commercial Finance
2 Business Unit Group Centre = part of non-legacy portfolio assigned to BU Group and activities in wind-down (e.g. ex-Antwerp Diamond Bank)
3 CCR at country level in local currency
| 30-06-2025, in millions of EUR | Slovakia | Hungary | Bulgaria | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 13 081 | 8 983 | 12 733 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| retail | 7 633 | 58% | 3 210 | 36% | 5 414 | 43% | |||
| o/w mortgages | 7 059 | 54% | 2 117 | 24% | 3 298 | 26% | |||
| o/w consumer finance | 574 | 4% | 1 092 | 12% | 2 116 | 17% | |||
| SME | 1 322 | 10% | 107 | 1% | 2 928 | 23% | |||
| corporate | 4 126 | 32% | 5 666 | 63% | 4 391 | 34% | |||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | |||
| total | 7 059 | 54% | 61% | 2 117 | 24% | 45% | 3 298 | 26% | 61% |
| o/w FX mortgages | 0 | 0% | - | 0 | 0% | 37% | 61 | 0% | 37% |
| o/w ind. LTV > 100% | 38 | 0% | - | 17 | 0% | 14 | 0% | - | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 8 713 | 67% | 4 804 | 53% | 4 153 | 33% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 3 570 | 27% | 3 934 | 44% | 7 913 | 62% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 575 | 4% | 163 | 2% | 426 | 3% | |||
| impaired loans (PD 10 - 12) | 205 | 2% | 78 | 1% | 240 | 2% | |||
| unrated | 19 | 0% | 4 | 0% | 1 | 0% | |||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | |||
| outstanding impaired loans | 205 | 90 | 44% | 78 | 30 | 38% | 240 | 127 | 53% |
| o/w PD 10 impaired loans | 95 | 22 | 24% | 50 | 15 | 29% | 97 | 30 | 31% |
| o/w more than 90 days past due (PD 11+12) | 110 | 68 | 62% | 27 | 15 | 55% | 143 | 97 | 68% |
| all impairments (stage 1+2+3) | 131 | 70 | 191 | ||||||
| o/w stage 1+2 impairments (incl. POCI) | 41 | 40 | 64 | ||||||
| o/w stage 3 impairments (incl. POCI) | 90 | 30 | 127 | ||||||
| 2024 Credit cost ratio (CCR)1 | -0.14% | -0.27% | 0.14% | ||||||
| 2025 Credit cost ratio (CCR)3 - YTD |
0.12% | 0.09% | 0.33% |
1 CCR at country level in local currency
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD. This regulation entered gradually into force as of 1 January 2014.
Based on CRR/CRD, profit can be included in CET1 capital only after the profit appropriation decision by the final decision body, for KBC Group it is the General Meeting. ECB can allow to include interim or annual profit in CET1 capital before the decision by the General Meeting. In that case, the foreseeable dividend should be deducted from the profit that is included in CET1. Until 1Q 2025 our Dividend Policy of "at least 50%" did not include a maximum, therefore, KBC Group did not request ECB approval to include interim or annual profit in CET1 capital before the decision by the General Meeting. As such, the annual profit of 2024 and the dividend re. 2024 were recognised in the official (transitional) CET1 of the 1st quarter 2025, which is reported after the General Meeting.
As from 2Q 2025 our updated Dividend Policy includes a pay-out range of 50%-65% (Payout ratio, including AT1 coupon), this allows KBC Group to request ECB approval to include 35% of the interim or annual profit in transitional CET1 capital before the decision by the General Meeting.
The 1H 2025 interim profit is included in the fully loaded CET1 taking into account 50% pay-out.
The general rule under CRR/CRD for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). As of the fourth quarter of 2020, the revised CRR/CRD requires the use of the equity method, unless the competent authority allows institutions to apply a different method. KBC Group has received ECB approval to continue to use the historical carrying value for risk weighting (250% from 1 January 2025, 370% before), after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRR/CRD, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC). This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The overall capital requirement (CET1) that KBC is to uphold is set at 10.81% (fully loaded, Danish Compromise which includes the CRR/CRD minimum requirement (4.50%), the Pillar 2 Requirement (1.06% P2R, taking into account CRD V Art 104a(4)) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% buffer for other systemically important banks, 0.10% Systemic Risk Buffer and 1.15% Countercyclical Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.25%. In line with CRD V Art. 104a(4), ECB allows banks to satisfy the P2R (1.83%, 3bps lower compared to 31 December 2024 which is explained by a lower add-on related to the back-stop shortfall for non-performing exposures defaulted before 01-04-2018) with additional tier-1 instruments (1.75% up to 1.5/8) and tier-2 instruments (1.75% up to 2/8) based on the same relative weights as allowed for meeting the 8% Pillar 1 Requirement. The CET1 requirement related to P2R now includes 100% of the 8bps add-on related to the back-stop shortfall for non-performing exposures defaulted before 01-04-2018.
Distributions (being dividend payments, payments related to additional tier 1 instruments or variable remuneration) are limited in case the combined buffer requirements described above are breached. This limitation is also referred to as "Maximum Distributable Amount" or "MDA" thresholds.
The next table provides an overview of the buffers KBC Group has compared to these thresholds, both on an actuals basis (i.e. versus the regulatory targets that apply at the reporting date) and a fully loaded basis (i.e. versus the regulatory targets that will apply going forward).
| Buffer vs. Overall Capital Requirement (in millions of EUR) |
30-06-2025 | 31-12-2024 | ||
|---|---|---|---|---|
| (consolidated, under CRR, Danish compromise method) | Fully loaded | Actuals | Fully loaded | Actuals |
| CET1 Pillar 1 minimum | 4.50% | 4.50% | 4.50% | 4.50% |
| Pillar 2 requirement to be satisfied with CET1 | 1.06% | 1.06% | 1.09% | 1.05% |
| Capital conservation buffer | 2.50% | 2.50% | 2.50% | 2.50% |
| Buffer for systemically important institutions (O-SII) | 1.50% | 1.50% | 1.50% | 1.50% |
| Systemic Risk Buffer (SRyB) | 0.10% | 0.10% | 0.14% | 0.14% |
| Entity-specific countercyclical buffer | 1.15% | 1.12% | 1.15% | 1.12% |
| Overall Capital Requirement (OCR) - with P2R split, CRD Art. 104a(4) | 10.81% | 10.79% | 10.88% | 10.80% |
| CET1 used to satisfy shortfall in AT1 bucket | -0.44% | -0.48% | 0.27% | 0.29% |
| CET1 used to satisfy shortfall in T2 bucket | 0.35% | 0.32% | 0.30% | 0.33% |
| CET1 requirement for MDA | 10.81% | 10.79% | 11.45% | 11.42% |
| CET1 capital | 18 413 | 18 138 | 17 947 | 16 621 |
| CET1 buffer (= buffer compared to MDA) | 4 765 | 4 729 | 4 212 | 2 919 |
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios | denominator | |||
|---|---|---|---|---|
| (in millions of EUR) | numerator | (total | ||
| 30-06-2025 | (common equity) |
weighted risk volume) |
ratio (%) | |
| Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 18 413 | 126 220 | 14.59% |
| Deduction Method | Fully loaded | 17 820 | 124 736 | 14.29% |
| Financial Conglomerates Directive | Fully loaded | 20 275 | 147 368 | 13.76% |
| Danish Compromise | Transitional | 18 138 | 124 315 | 14.59% |
| Deduction Method | Transitional | 17 504 | 122 730 | 14.26% |
| Financial Conglomerates Directive | Transitional | 20 000 | 145 463 | 13.75% |
KBC's fully loaded CET1 ratio of 14.59% at the end of June 2025 represents a solid capital buffer of 3.78% compared with the Maximum Distributable Amount (MDA) of 10.81%.
The EBA Monitoring report on AT1, Tier 2 and TLAC / MREL eligible liabilities instruments (27 June 2024) recommends to use the carrying amounts (including accrued interest and hedge adjustments) instead of nominal amounts for own funds calculation. KBC has applied this EBA recommendation as from 30-09-2024. Implementation of this approach increases the volatility in the Tier 2 capital: as at 30-06-2025 it has a 27 million euros positive impact on Tier 2 capital at KBC Group level (compared to 47 million euros on 31-12-2024).
| 30-06-2025 | 30-06-2025 | 31-12-2024 | 31-12-2024 | |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital (after profit appropriation) | 23 915 | 23 641 | 22 374 | 21 048 |
| Tier-1 capital | 21 277 | 21 002 | 19 811 | 18 485 |
| Common equity | 18 413 | 18 138 | 17 947 | 16 621 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 21 975 | 21 975 | 21 589 | 18 932 |
| Intangible fixed assets, incl deferred tax impact (-) | - 768 | - 768 | - 743 | - 743 |
| Goodwill on consolidation, incl deferred tax impact (-) | - 1 062 | - 1 062 | - 1 052 | - 1 052 |
| Minority interests | 0 | 0 | 0 | 0 |
| Hedging reserve (cash flow hedges) (-) | 233 | 233 | 508 | 508 |
| Valuation diff. in financial liabilities at fair value - own credit risk (-) | - 28 | - 28 | - 29 | - 29 |
| Value adjustment due to the requirements for prudent valuation (-) | - 36 | - 36 | - 35 | - 35 |
| Dividend payout (-) | - 732 | - 1 014 | - 1 249 | 0 |
| Share buyback (part not yet executed) (-) | 0 | 0 | 0 | 0 |
| Coupon of AT1 instruments (-) | - 31 | - 31 | - 27 | - 27 |
| Deduction re. financing provided to shareholders (-) | - 20 | - 20 | - 23 | - 23 |
| Deduction re. Irrevocable payment commitments (-) | - 87 | - 87 | - 90 | - 90 |
| Deduction re NPL backstops (-) | - 251 | - 251 | - 205 | - 205 |
| Deduction re pension plan assets (-) | - 171 | - 171 | - 205 | - 205 |
| IRB provision shortfall (-) | - 263 | - 256 | - 141 | - 66 |
| Deferred tax assets on losses carried forward (-) | - 347 | - 347 | - 353 | - 353 |
| Transitional adjustments to CET1 | 0 | 0 | 0 | 7 |
| Limit on deferred tax assets from timing differences relying on future profitability and significant participations in financial sector entities (-) |
0 | 0 | 0 | 0 |
| Additional going concern capital | 2 864 | 2 864 | 1 864 | 1 864 |
| CRR compliant AT1 instruments | 2 864 | 2 864 | 1 864 | 1 864 |
| Minority interests to be included in additional going concern capital | 0 | 0 | 0 | 0 |
| Tier 2 capital | 2 637 | 2 639 | 2 563 | 2 563 |
| IRB provision excess (+) | 281 | 282 | 167 | 167 |
| Transitional adjustments to T2 | 0 | 0 | 0 | 0 |
| Subordinated liabilities | 2 357 | 2 357 | 2 396 | 2 396 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 | 0 | 0 |
| Total weighted risk volume | 126 220 | 124 315 | 119 945 | 119 950 |
| Banking | 119 266 | 117 361 | 110 082 | 110 087 |
| Insurance | 6 171 | 6 171 | 9 133 | 9 133 |
| Holding activities | 791 | 791 | 734 | 734 |
| Elimination of intercompany transactions | - 9 | - 9 | - 5 | - 5 |
| Solvency ratios | ||||
| Common equity ratio | 14.59% | 14.59% | 14.96% | 13.86% |
| Tier-1 ratio | 16.86% | 16.89% | 16.52% | 15.41% |
| Total capital ratio | 18.95% | 19.02% | 18.65% | 17.55% |
Note:
• For the composition of the banking RWA, see section 'Solvency banking and insurance activities separately' further in this report.
• As at 30-06-2025, the difference between the fully loaded total own funds (23 915 million euros, interim profit after 50% pay-out re. 2025 is included) and the transitional own funds (23 641 million euros, interim profit is included based on the calculation method in line with Decision (EU) 2015/656 of the European Central Bank (ECB/2015/4)) is explained by the higher amount of the dividend accrual in the transitional own funds (-282 million euros) and the IRB excess/shortfall (8 million euros).
• In May 2025, KBC Group issued a new AT1 for an amount of 1 billion euros with a first call date on 27-11-2030.
• At year-end 2024, the difference between the fully loaded total own funds (22 374 million euros; profit and dividend re. 2024 is included) and the transitional own funds (21 048 million euros; profit and dividend re. 2024 is not included) is explained by the net result for 2024 (+3 333 million euros under the Danish Compromise method), the ordinary dividend for 2024 pay-out (-1 645 million euros dividend accrual, of which -396 million euros interim dividend of 2024), the extraordinary interim dividend (-280 million euros, paid out in 2Q 2024), the impact of the IFRS 9 transitional measures and IRB excess/shortfall (-81 million euros).
| Leverage ratio KBC Group | 30-06-2025 | 30-06-2025 | 31-12-2024 | 31-12-2024 |
|---|---|---|---|---|
| In millions of EUR | Fully loaded | Transitional | Fully loaded | Transitional |
| Tier-1 capital | 21 277 | 21 002 | 19 811 | 18 485 |
| Total exposures | 380 048 | 380 048 | 360 085 | 360 092 |
| Total Assets | 390 669 | 390 669 | 373 048 | 373 048 |
| Deconsolidation KBC Insurance | -34 164 | -34 164 | -33 734 | -33 734 |
| Transitional adjustment | 0 | 0 | 0 | 7 |
| Adjustment for derivatives | - 842 | - 842 | - 885 | - 885 |
| Adjustment for regulatory corrections in determining Tier-1 capital | -2 910 | -2 910 | -2 681 | -2 681 |
| Adjustment for securities financing transaction exposures | 1 511 | 1 511 | 1 686 | 1 686 |
| Central Bank exposure | 0 | 0 | 0 | 0 |
| Off-balance sheet exposures | 25 784 | 25 784 | 22 651 | 22 651 |
| Leverage ratio | 5.60% | 5.53% | 5.50% | 5.13% |
At the end of June 2025, the fully loaded leverage ratio increased compared to December 2024, mainly driven by higher AT1 capital (1 new AT1 instrument issued in 2Q25 – 1bn EUR) and by high profit recognition.
. . .
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016.
The tables below show the tier-1 and CAD ratios calculated under CRR/CRD for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| Regulatory capital requirements KBC Bank (consolidated) | 30-06-2025 | 30-06-2025 | 31-12-2024 | 31-12-2024 |
|---|---|---|---|---|
| (in millions of EUR) | Fully loaded | Transitional | Fully loaded | Transitional |
| Total regulatory capital, after profit appropriation | 22 014 | 21 602 | 20 296 | 18 981 |
| Tier-1 capital | 19 388 | 18 975 | 17 755 | 16 440 |
| Common equity | 16 524 | 16 111 | 15 891 | 14 576 |
| Parent shareholders' equity | 19 594 | 19 594 | 18 559 | 16 665 |
| Solvency adjustments | -3 070 | -3 483 | -2 668 | -2 088 |
| Additional going concern capital | 2 864 | 2 864 | 1 864 | 1 864 |
| Tier-2 capital | 2 626 | 2 627 | 2 541 | 2 541 |
| Total weighted risk volume | 119 411 | 117 506 | 110 082 | 110 087 |
| Credit risk | 100 605 | 99 200 | 94 213 | 94 218 |
| Market risk | 2 494 | 1 994 | 2 026 | 2 026 |
| Operation risk | 16 313 | 16 313 | 13 843 | 13 843 |
| Common equity ratio | 13.8% | 13.7% | 14.4% | 13.2% |
(in millions of EUR)
| (in millions of EUR) | ||
|---|---|---|
| Own Funds | 4 648 | 4 392 |
| Tier 1 | 4 133 | 3 873 |
| IFRS Parent shareholders equity | 3 836 | 3 331 |
| Dividend payout | - 202 | - 91 |
| Deduction intangible assets and goodwill (after tax) | - 212 | - 207 |
| Valuation differences (after tax) | 515 | 633 |
| Volatility adjustment | 163 | 189 |
| Other | 32 | 18 |
| Tier 2 | 501 | 501 |
| Subordinated liabilities | 501 | 501 |
| Tier 3 | 14 | 18 |
| Deferred tax assets | 14 | 18 |
| Solvency Capital Requirement (SCR) | 2 186 | 2 196 |
| Market risk | 1 497 | 1 533 |
| Non-life | 828 | 821 |
| Life | 1 285 | 1 222 |
| Health | 274 | 321 |
| Counterparty | 145 | 121 |
| Diversification | -1 387 | -1 385 |
| Other | - 456 | - 435 |
| Solvency II ratio | 213% | 200% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
In June 2025, the SRB formally communicated to KBC binding MREL targets (under BRRD2), expressed as a percentage of Risk Weighted Assets (RWA) and Leverage Ratio Exposure Amount (LRE):
Besides a total MREL amount, BRRD2 also requires KBC to maintain a certain part of MREL in subordinated format (i.e. instruments subordinated to liabilities, excluded from bail-in).
The binding subordinated MREL targets are:
At the end of June 2025, the MREL ratio stands at 30.8% as a % of RWA (versus 30.7% as at the end 2024) and at 10.1% as % of LRE (versus 10.2% as at the end of 2024).
(1) Combined Buffer Requirement (transitional) = Conservation Buffer (2.50%) + O-SII Buffer (1.50%) + Countercyclical Buffer (1.12%) + Systemic Risk Buffer (0.10%) comes on top of the MREL target as a percentage of RWA.
Details on our segments or business units are available in the company presentation.
Note: The ECB approved to apply the IFRS9 transitional arrangements from 2Q 2020, as such the difference between fully loaded and the transitional measures are assigned to Group Centre. In other words, the RWA, allocated capital and the ROAC of the different countries remain based on fully loaded.
| KBC Group | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 1 509 | 1 421 | 1 433 | 1 394 | 1 379 |
| Insurance revenues before reinsurance | 788 | 773 | 764 | 740 | 726 |
| Non-life | 667 | 648 | 640 | 631 | 613 |
| Life | 121 | 125 | 124 | 109 | 114 |
| Dividend income | 33 | 9 | 13 | 11 | 26 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 34 | - 45 | - 74 | - 42 | 3 |
| Net fee and commission income | 667 | 690 | 700 | 641 | 623 |
| Net other income | 77 | 67 | 27 | 45 | 51 |
| TOTAL INCOME | 3 041 | 2 915 | 2 863 | 2 787 | 2 809 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 1 020 | - 1 498 | - 1 126 | - 1 058 | - 950 |
| Total Opex without bank and insurance tax | - 1 125 | - 1 106 | - 1 201 | - 1 135 | - 1 074 |
| Total bank and insurance tax | - 27 | - 539 | - 55 | - 47 | - 2 |
| Minus: Opex allocated to insurance service expenses | 132 | 148 | 131 | 124 | 126 |
| Insurance service expenses before reinsurance | - 608 | - 622 | - 635 | - 688 | - 590 |
| Of which Insurance commissions paid | - 105 | - 102 | - 103 | - 99 | - 92 |
| Non-life | - 541 | - 543 | - 561 | - 615 | - 514 |
| of which Non-life - Claim related expenses | - 342 | - 337 | - 364 | - 427 | - 331 |
| Life | - 67 | - 79 | - 74 | - 72 | - 76 |
| Net result from reinsurance contracts held | - 15 | - 9 | - 4 | 28 | - 24 |
| Impairment | - 124 | - 38 | - 78 | - 69 | - 85 |
| on FA at amortised cost and at FVOCI | - 116 | - 38 | - 50 | - 61 | - 72 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 8 | 0 | - 28 | - 7 | - 13 |
| Share in results of associated companies and joint ventures | 1 | 0 | - 1 | 78 | 2 |
| RESULT BEFORE TAX | 1 275 | 747 | 1 020 | 1 079 | 1 162 |
| Income tax expense | - 257 | - 202 | 96 | - 211 | - 237 |
| RESULT AFTER TAX | 1 018 | 546 | 1 115 | 868 | 925 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 1 018 | 546 | 1 116 | 868 | 925 |
| Banking | 829 | 395 | 967 | 774 | 774 |
| Insurance | 181 | 140 | 139 | 104 | 139 |
| Holding activities | 9 | 11 | 10 | - 9 | 13 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 202 031 | 197 326 | 192 067 | 188 623 | 187 502 |
| of which Mortgage loans (end of period) | 81 109 | 79 429 | 78 059 | 76 926 | 76 236 |
| Customer deposits and debt certificates excl. repos (end of period) | 284 861 | 271 716 | 271 087 | 263 071 | 271 610 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 29 499 | 29 296 | 29 596 | 29 020 | 28 272 |
| Liabilities under investment contracts (IFRS 9) | 15 757 | 15 631 | 15 671 | 15 193 | 14 780 |
| Insurance contract liabilities (IFRS 17) | 13 742 | 13 665 | 13 925 | 13 827 | 13 492 |
| Non-life insurance | 3 280 | 3 247 | 3 186 | 3 186 | 3 029 |
| Performance Indicators | |||||
| Risk-weighted assets, banking fully loaded, end of period) | 126 220 | 124 789 | 119 945 | 116 817 | 115 635 |
| Required capital, insurance (end of period) | 2 186 | 2 171 | 2 196 | 2 206 | 2 153 |
| Allocated capital (end of period) | 15 247 | 15 076 | 14 297 | 13 965 | 13 783 |
| Return on allocated capital (ROAC, YTD) | 21% | 15% | 25% | 22% | 21% |
| Cost/income ratio without banking and insurance tax (YTD) | 41% | 41% | 43% | 43% | 42% |
| Combined ratio, non-life insurance (YTD) Net interest margin, banking (QTD) |
85% 2.08% |
86% 2.05% |
90% 2.08% |
89% 2.08% |
87% 2.10% |
| Business unit Belgium | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 900 | 830 | 837 | 828 | 831 |
| Insurance revenues before reinsurance | 470 | 471 | 469 | 447 | 445 |
| Non-life | 394 | 390 | 387 | 379 | 371 |
| Life | 76 | 81 | 83 | 68 | 74 |
| Dividend income | 32 | 9 | 12 | 7 | 24 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | - 93 | - 71 | - 113 | - 65 | - 64 |
| Net fee and commission income | 430 | 454 | 446 | 419 | 409 |
| Net other income | 72 | 61 | 51 | 49 | 46 |
| TOTAL INCOME | 1 811 | 1 753 | 1 703 | 1 686 | 1 692 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 552 | - 900 | - 589 | - 563 | - 503 |
| Total Opex without bank and insurance tax | - 627 | - 628 | - 666 | - 634 | - 609 |
| Total bank and insurance tax | 0 | - 356 | 0 | 0 | 32 |
| Minus: Opex allocated to insurance service expenses | 75 | 84 | 76 | 71 | 73 |
| Insurance service expenses before reinsurance | - 362 | - 383 | - 386 | - 360 | - 363 |
| Of which Insurance commissions paid | - 64 | - 63 | - 63 | - 62 | - 59 |
| Non-life | - 320 | - 330 | - 337 | - 311 | - 311 |
| of which Non-life - Claim related expenses | - 213 | - 224 | - 228 | - 209 | - 210 |
| Life | - 41 | - 53 | - 49 | - 49 | - 53 |
| Net result from reinsurance contracts held | - 15 | - 4 | - 10 | - 20 | - 9 |
| Impairment | - 79 | - 24 | - 58 | - 42 | - 123 |
| on FA at amortised cost and at FVOCI | - 77 | - 24 | - 48 | - 40 | - 122 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 2 | 0 | - 11 | - 2 | - 1 |
| Share in results of associated companies and joint ventures | 1 | 1 | 0 | 78 | 1 |
| RESULT BEFORE TAX | 804 | 443 | 660 | 779 | 694 |
| Income tax expense | - 198 | - 163 | - 173 | - 182 | - 176 |
| RESULT AFTER TAX | 607 | 281 | 487 | 598 | 518 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 607 | 281 | 487 | 598 | 519 |
| Banking | 487 | 187 | 391 | 503 | 407 |
| Insurance | 120 | 94 | 96 | 95 | 111 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 128 894 | 126 204 | 123 887 | 121 832 | 121 459 |
| of which Mortgage loans (end of period) | 47 488 | 46 835 | 46 297 | 45 970 | 45 613 |
| Customer deposits and debt certificates excl. repos (end of period) | 177 004 | 163 206 | 164 483 | 157 465 | 165 002 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 27 741 | 27 573 | 27 862 | 27 266 | 26 530 |
| Liabilities under investment contracts (IFRS 9) | 15 757 | 15 631 | 15 671 | 15 193 | 14 780 |
| Insurance contract liabilities (IFRS 17) | 11 983 | 11 942 | 12 191 | 12 073 | 11 750 |
| Non-life insurance | 2 441 | 2 424 | 2 371 | 2 361 | 2 298 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (fully loaded, end of period) | 73 101 | 71 982 | 67 340 | 65 297 | 63 753 |
| Required capital, insurance (end of period) | 1 829 | 1 849 | 1 868 | 1 906 | 1 801 |
| Allocated capital (end of period) | 9 782 | 9 681 | 9 221 | 9 036 | 8 763 |
| Return on allocated capital (ROAC, YTD) | 19% | 12% | 21% | 21% | 18% |
| Cost/income ratio without banking and insurance tax (YTD) | 39% | 39% | 41% | 41% | 40% |
| Combined ratio, non-life insurance (YTD) | 86% | 86% | 88% | 87% | 86% |
| Net interest margin, banking (QTD) | 1.92% | 1.87% | 1.90% | 1.94% | 1.97% |
| Business unit Czech Republic | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 348 | 336 | 335 | 325 | 323 |
| Insurance revenues before reinsurance | 165 | 156 | 153 | 151 | 144 |
| Non-life | 139 | 130 | 126 | 126 | 119 |
| Life | 27 | 26 | 26 | 25 | 25 |
| Dividend income | 0 | 0 | 0 | 0 | 1 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 24 | 17 | 28 | 11 | 10 |
| Net fee and commission income | 88 | 94 | 97 | 87 | 84 |
| Net other income | 2 | 2 | 0 | 0 | - 1 |
| TOTAL INCOME | 628 | 605 | 614 | 573 | 561 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 201 | - 228 | - 222 | - 207 | - 196 |
| Total Opex without bank and insurance tax | - 234 | - 231 | - 249 | - 234 | - 221 |
| Total bank and insurance tax | 4 | - 25 | - 1 | - 1 | - 3 |
| Minus: Opex allocated to insurance service expenses | 29 | 28 | 28 | 29 | 27 |
| Insurance service expenses before reinsurance | - 131 | - 115 | - 130 | - 198 | - 104 |
| Of which Insurance commissions paid | - 22 | - 21 | - 21 | - 20 | - 16 |
| Non-life | - 118 | - 100 | - 115 | - 185 | - 91 |
| of which Non-life - Claim related expenses | - 72 | - 58 | - 73 | - 143 | - 53 |
| Life | - 14 | - 14 | - 16 | - 13 | - 12 |
| Net result from reinsurance contracts held | 1 | - 5 | 10 | 60 | - 6 |
| Impairment | - 12 | - 14 | 11 | - 17 | 41 |
| on FA at amortised cost and at FVOCI | - 12 | - 14 | 13 | - 17 | 41 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | 0 | - 2 | 0 | - 1 |
| Share in results of associated companies and joint ventures | 0 | - 1 | - 1 | 0 | 0 |
| RESULT BEFORE TAX | 285 | 243 | 282 | 211 | 297 |
| Income tax expense | - 45 | - 36 | - 44 | - 32 | - 52 |
| RESULT AFTER TAX | 240 | 207 | 238 | 179 | 244 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 240 | 207 | 238 | 179 | 244 |
| Banking | 208 | 176 | 210 | 165 | 213 |
| Insurance | 32 | 32 | 28 | 15 | 31 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 41 569 | 40 530 | 38 338 | 37 756 | 37 422 |
| of which Mortgage loans (end of period) | 21 023 | 20 480 | 20 028 | 19 738 | 19 685 |
| Customer deposits and debt certificates excl. repos (end of period) | 54 594 | 53 942 | 52 709 | 51 867 | 51 939 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 837 | 831 | 835 | 862 | 868 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 837 | 831 | 835 | 862 | 868 |
| Non-life insurance | 421 | 411 | 413 | 422 | 349 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (fully loaded, end of period) | 21 119 | 21 533 | 18 530 | 18 389 | 18 124 |
| Required capital, insurance (end of period) | 185 | 176 | 169 | 166 | 170 |
| Allocated capital (end of period) | 2 482 | 2 519 | 2 193 | 2 174 | 2 149 |
| Return on allocated capital (ROAC, YTD) | 37% | 35% | 40% | 39% | 42% |
| Cost/income ratio without banking and insurance tax (YTD) | 41% | 42% | 43% | 43% | 42% |
| Combined ratio, non-life insurance (YTD) | 83% | 81% | 86% | 87% | 80% |
| Net interest margin, banking (QTD) | 2.44% | 2.44% | 2.46% | 2.40% | 2.42% |
| Business unit International Markets | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 331 | 328 | 328 | 321 | 317 |
| Insurance revenues before reinsurance | 149 | 143 | 139 | 138 | 133 |
| Non-life | 131 | 126 | 123 | 123 | 119 |
| Life | 18 | 18 | 16 | 15 | 15 |
| Dividend income | 0 | 0 | 0 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
17 | 10 | 7 | 8 | 14 |
| Net fee and commission income | 150 | 143 | 158 | 136 | 131 |
| Net other income | 7 | 5 | - 21 | 0 | 9 |
| TOTAL INCOME | 654 | 629 | 610 | 604 | 605 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 225 | - 332 | - 264 | - 236 | - 215 |
| Total Opex without bank and insurance tax | - 221 | - 213 | - 236 | - 214 | - 207 |
| Total bank and insurance tax | - 31 | - 155 | - 55 | - 46 | - 32 |
| Minus: Opex allocated to insurance service expenses | 27 | 35 | 26 | 25 | 25 |
| Insurance service expenses before reinsurance | - 115 | - 124 | - 120 | - 127 | - 121 |
| Of which Insurance commissions paid | - 19 | - 18 | - 19 | - 17 | - 17 |
| Non-life | - 102 | - 113 | - 110 | - 117 | - 111 |
| of which Non-life - Claim related expenses | - 56 | - 56 | - 65 | - 73 | - 67 |
| Life | - 12 | - 11 | - 10 | - 9 | - 11 |
| Net result from reinsurance contracts held | - 6 | - 3 | - 2 | 6 | - 3 |
| Impairment | - 34 | - 4 | - 15 | - 9 | - 3 |
| on FA at amortised cost and at FVOCI | - 28 | - 4 | 0 | - 4 | 9 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 6 | 0 | - 15 | - 6 | - 11 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 276 | 165 | 209 | 239 | 263 |
| Income tax expense | - 39 | - 30 | - 34 | - 34 | - 39 |
| RESULT AFTER TAX | 237 | 135 | 175 | 205 | 224 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 237 | 135 | 175 | 205 | 224 |
| Banking | 207 | 118 | 158 | 187 | 212 |
| Insurance | 29 | 17 | 17 | 18 | 12 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 31 568 | 30 592 | 29 842 | 29 035 | 28 621 |
| of which Mortgage loans (end of period) | 12 599 | 12 113 | 11 735 | 11 218 | 10 937 |
| Customer deposits and debt certificates excl. repos (end of period) | 33 271 | 32 905 | 32 832 | 32 189 | 31 730 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 921 | 892 | 899 | 891 | 875 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 921 | 892 | 899 | 891 | 875 |
| Non-life insurance | 394 | 397 | 382 | 379 | 362 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (fully loaded, end of period) | 24 345 | 23 699 | 23 757 | 22 758 | 23 382 |
| Required capital, insurance (end of period) | 199 | 193 | 188 | 183 | 179 |
| Allocated capital (end of period) | 2 848 | 2 772 | 2 782 | 2 668 | 2 732 |
| Return on allocated capital (ROAC, YTD) | 27% | 19% | 28% | 29% | 27% |
| Cost/income ratio without banking and insurance tax (YTD) | 37% | 37% | 38% | 37% | 36% |
| Combined ratio, non-life insurance (YTD) | 89% | 95% | 96% | 97% | 100% |
| Net interest margin, banking (QTD) | 3.01% | 3.13% | 3.16% | 3.18% | 3.27% |
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 85% in 1H 2025, 87% in 1Q 2025, 93% in 2024, 92% in 9M 2024 & 1H 2024.
| Slovakia | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 71 | 72 | 70 | 69 | 69 |
| Insurance revenues before reinsurance | 29 | 28 | 28 | 28 | 27 |
| Non-life | 23 | 22 | 22 | 22 | 22 |
| Life | 6 | 6 | 6 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 4 | 4 | 0 | - 1 | 2 |
| Net fee and commission income | 23 | 23 | 25 | 21 | 21 |
| Net other income | 3 | 3 | 1 | 0 | 5 |
| TOTAL INCOME | 130 | 130 | 124 | 116 | 125 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 63 | - 64 | - 69 | - 69 | - 66 |
| Total Opex without bank and insurance tax | - 68 | - 67 | - 68 | - 66 | - 64 |
| Total bank and insurance tax | - 2 | - 4 | - 8 | - 9 | - 8 |
| Minus: Opex allocated to insurance service expenses | 7 | 7 | 7 | 7 | 7 |
| Insurance service expenses before reinsurance | - 24 | - 25 | - 29 | - 28 | - 32 |
| Of which Insurance commissions paid | - 4 | - 4 | - 4 | - 3 | - 3 |
| Non-life | - 19 | - 21 | - 26 | - 24 | - 28 |
| of which Non-life - Claim related expenses | - 11 | - 13 | - 17 | - 16 | - 21 |
| Life | - 5 | - 4 | - 3 | - 4 | - 4 |
| Net result from reinsurance contracts held | - 1 | - 1 | 1 | 3 | 0 |
| Impairment | - 11 | 2 | 3 | - 3 | 6 |
| on FA at amortised cost and at FVOCI | - 10 | 2 | 4 | - 3 | 6 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | - 1 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 31 | 43 | 30 | 20 | 33 |
| Income tax expense | - 6 | - 9 | - 4 | - 4 | - 7 |
| RESULT AFTER TAX | 25 | 34 | 26 | 16 | 27 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 25 | 34 | 26 | 16 | 27 |
| Banking | 22 | 31 | 25 | 13 | 30 |
| Insurance | 3 | 3 | 1 | 2 | - 4 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 12 475 | 12 195 | 11 887 | 11 672 | 11 667 |
| of which Mortgage loans (end of period) | 7 023 | 6 849 | 6 729 | 6 622 | 6 578 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 083 | 8 995 | 9 360 | 9 228 | 8 961 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 182 | 166 | 174 | 173 | 173 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 182 | 166 | 174 | 173 | 173 |
| Non-life insurance | 76 | 77 | 75 | 72 | 68 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (fully loaded, end of period) | 7 694 | 7 429 | 7 949 | 7 768 | 7 827 |
| Required capital, insurance (end of period) | 35 | 34 | 33 | 32 | 32 |
| Allocated capital (end of period) | 872 | 842 | 901 | 880 | 886 |
| Return on allocated capital (ROAC, YTD) | 14% | 16% | 11% | 11% | 14% |
| Cost/income ratio without banking and insurance tax (YTD) | 55% | 54% | 57% | 56% | 54% |
| Combined ratio, non-life insurance (YTD) | 94% | 98% | 112% | 112% | 120% |
| (in millions of EUR) 2Q 2025 1Q 2025 4Q 2024 3Q 2024 2Q 2024 Breakdown P&L Net interest income 146 144 141 143 138 Insurance revenues before reinsurance 54 55 50 52 50 Non-life 48 49 45 47 45 Life 6 6 5 5 5 Dividend income 0 0 0 0 0 Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) 13 6 8 9 12 Net fee and commission income 85 81 92 75 71 Net other income 3 1 - 28 - 2 3 TOTAL INCOME 301 287 263 277 275 Operating expenses (excluding opex allocated to insurance service expenses) - 110 - 188 - 124 - 103 - 87 Total Opex without bank and insurance tax - 82 - 79 - 87 - 75 - 72 Total bank and insurance tax - 38 - 128 - 46 - 37 - 24 Minus: Opex allocated to insurance service expenses 10 20 9 9 9 Insurance service expenses before reinsurance - 42 - 54 - 42 - 53 - 44 Of which Insurance commissions paid - 4 - 3 - 3 - 3 - 4 Non-life - 38 - 50 - 39 - 50 - 40 of which Non-life - Claim related expenses - 18 - 18 - 21 - 31 - 21 Life - 3 - 4 - 3 - 3 - 4 Net result from reinsurance contracts held - 2 - 1 - 1 6 - 2 Impairment - 8 0 - 15 1 - 3 on FA at amortised cost and at FVOCI - 3 0 - 1 6 8 on goodwill 0 0 0 0 0 other - 5 0 - 14 - 5 - 11 Share in results of associated companies and joint ventures 0 0 0 0 0 RESULT BEFORE TAX 140 45 81 127 139 Income tax expense - 18 - 10 - 17 - 17 - 18 RESULT AFTER TAX 122 35 65 110 121 attributable to minority interests 0 0 0 0 0 attributable to equity holders of the parent 122 35 65 110 121 Banking 111 33 57 105 115 Insurance 11 2 8 5 6 Breakdown Loans and deposits Total customer loans excluding reverse repos (end of period) 7 299 6 996 6 857 6 860 6 773 of which Mortgage loans (end of period) 2 104 2 023 1 937 1 980 1 903 Customer deposits and debt certificates excl. repos (end of period) 10 011 10 100 9 607 9 587 9 536 Insurance related liabilities (including Inv. Contracts) Life insurance 309 310 308 316 315 Liabilities under investment contracts (IFRS 9) 0 0 0 0 0 Insurance contract liabilities (IFRS 17) 309 310 308 316 315 Non-life insurance 122 126 119 125 119 Performance Indicators Risk-weighted assets, banking (fully loaded, end of period) 6 991 6 865 6 661 6 491 6 777 Required capital, insurance (end of period) 68 67 64 62 62 Allocated capital (end of period) 829 814 791 771 802 Return on allocated capital (ROAC, YTD) 39% 17% 44% 48% 43% Cost/income ratio without banking and insurance tax (YTD) 29% 29% 29% 27% 26% Combined ratio, non-life insurance (YTD) 94% 104% 100% 104% 109% |
Hungary | |||
|---|---|---|---|---|
Note: The combined ratio, non-life insurance includes a significant windfall tax fully booked in first quarter. Excluding the windfall tax, the combined ratio amounted to 84% in 1H 2025, 84% in 1Q 2025, 91% in 2024, 92% in 9M 2024, and 90% in 1H 2024.
| Bulgaria | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | 114 | 112 | 117 | 110 | 110 |
| Insurance revenues before reinsurance | 67 | 60 | 61 | 59 | 57 |
| Non-life | 60 | 54 | 56 | 54 | 52 |
| Life | 6 | 6 | 5 | 5 | 5 |
| Dividend income | 0 | 0 | 0 | 1 | 0 |
| Net result from financial instruments at fair value through profit or loss & | |||||
| Insurance finance income and expense (for contracts issued) | 0 | - 1 | 0 | - 1 | - 1 |
| Net fee and commission income | 41 | 39 | 41 | 40 | 38 |
| Net other income | 1 | 1 | 6 | 2 | 1 |
| TOTAL INCOME | 223 | 212 | 224 | 211 | 205 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 52 | - 81 | - 71 | - 64 | - 62 |
| Total Opex without bank and insurance tax | - 70 | - 67 | - 81 | - 72 | - 71 |
| Total bank and insurance tax | 9 | - 22 | 0 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 10 | 9 | 10 | 9 | 9 |
| Insurance service expenses before reinsurance | - 49 | - 46 | - 49 | - 45 | - 45 |
| Of which Insurance commissions paid | - 11 | - 11 | - 11 | - 10 | - 10 |
| Non-life | - 45 | - 43 | - 46 | - 43 | - 42 |
| of which Non-life - Claim related expenses | - 27 | - 25 | - 27 | - 26 | - 26 |
| Life | - 3 | - 3 | - 3 | - 3 | - 3 |
| Net result from reinsurance contracts held | - 2 | - 2 | - 2 | - 2 | - 1 |
| Impairment | - 15 | - 6 | - 4 | - 7 | - 5 |
| on FA at amortised cost and at FVOCI | - 15 | - 6 | - 3 | - 7 | - 5 |
| on goodwill | 0 | 0 | 0 | 0 | 0 |
| other | 0 | 0 | - 1 | - 1 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 105 | 77 | 98 | 92 | 91 |
| Income tax expense | - 15 | - 11 | - 14 | - 12 | - 14 |
| RESULT AFTER TAX | 90 | 66 | 85 | 80 | 76 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 90 | 66 | 85 | 80 | 76 |
| Banking | 75 | 54 | 76 | 69 | 67 |
| Insurance | 15 | 12 | 8 | 11 | 9 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 11 794 | 11 401 | 11 098 | 10 503 | 10 182 |
| of which Mortgage loans (end of period) | 3 471 | 3 241 | 3 068 | 2 616 | 2 456 |
| Customer deposits and debt certificates excl. repos (end of period) | 14 177 | 13 811 | 13 865 | 13 373 | 13 234 |
| Insurance related liabilities (including Inv. Contracts) | |||||
| Life insurance | 430 | 416 | 417 | 402 | 387 |
| Liabilities under investment contracts (IFRS 9) | 0 | 0 | 0 | 0 | 0 |
| Insurance contract liabilities (IFRS 17) | 430 | 416 | 417 | 402 | 387 |
| Non-life insurance | 195 | 194 | 188 | 182 | 176 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (fully loaded, end of period) | 9 660 | 9 405 | 9 148 | 8 499 | 8 778 |
| Required capital, insurance (end of period) | 96 | 92 | 91 | 89 | 85 |
| Allocated capital (end of period) | 1 147 | 1 116 | 1 090 | 1 017 | 1 044 |
| Return on allocated capital (ROAC, YTD) | 28% | 24% | 29% | 29% | 27% |
| Cost/income ratio without banking and insurance tax (YTD) | 37% | 37% | 40% | 40% | 40% |
| Combined ratio, non-life insurance (YTD) | 83% | 85% | 86% | 85% | 83% |
| Business unit Group Centre | |||||
|---|---|---|---|---|---|
| (in millions of EUR) | 2Q 2025 | 1Q 2025 | 4Q 2024 | 3Q 2024 | 2Q 2024 |
| Breakdown P&L | |||||
| Net interest income | - 70 | - 73 | - 68 | - 80 | - 92 |
| Insurance revenues before reinsurance | 4 | 3 | 4 | 4 | 4 |
| Non-life | 4 | 3 | 4 | 4 | 4 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 1 | 0 | 0 | 2 | 1 |
| Net result from financial instruments at fair value through profit or loss & Insurance finance income and expense (for contracts issued) |
18 | 0 | 4 | 4 | 42 |
| Net fee and commission income | 0 | - 1 | - 1 | - 1 | - 1 |
| Net other income | - 5 | - 1 | - 2 | - 4 | - 3 |
| TOTAL INCOME | - 52 | - 72 | - 63 | - 76 | - 49 |
| Operating expenses (excluding opex allocated to insurance service expenses) | - 43 | - 38 | - 50 | - 52 | - 36 |
| Total Opex without bank and insurance tax | - 43 | - 35 | - 51 | - 53 | - 37 |
| Total bank and insurance tax | 0 | - 4 | 0 | 0 | 0 |
| Minus: Opex allocated to insurance service expenses | 1 | 1 | 1 | 1 | 1 |
| Insurance service expenses before reinsurance | - 1 | 0 | 1 | - 2 | - 1 |
| Of which Insurance commissions paid | 0 | 0 | 0 | 0 | 0 |
| Non-life | - 1 | 0 | 1 | - 2 | - 1 |
| of which Non-life - Claim related expenses | 0 | 1 | 2 | - 2 | - 1 |
| Life | 0 | 0 | 0 | 0 | 0 |
| Net result from reinsurance contracts held | 4 | 3 | - 3 | - 18 | - 6 |
| Impairment | 1 | 3 | - 16 | - 1 | 1 |
| on FA at amortised cost and at FVOCI | 1 | 3 | - 15 | - 1 | 1 |
| other | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | - 91 | - 104 | - 131 | - 150 | - 92 |
| Income tax expense | 25 | 27 | 346 | 36 | 30 |
| RESULT AFTER TAX | - 65 | - 77 | 215 | - 114 | - 61 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | - 65 | - 77 | 215 | - 114 | - 61 |
| Banking | - 73 | - 86 | 207 | - 81 | - 59 |
| Insurance | - 1 | - 2 | - 2 | - 24 | - 16 |
| Holding activities | 9 | 11 | 10 | - 9 | 13 |
| Breakdown Loans and deposits | |||||
| Total customer loans excluding reverse repos (end of period) | 0 | 0 | 0 | 0 | 0 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 19 992 | 21 662 | 21 063 | 21 550 | 22 938 |
| Performance Indicators | |||||
| Risk-weighted assets, banking (end of period,fully loaded) | 1 483 | 1 404 | 1 184 | 1 241 | 1 243 |
| Risk-weighted assets, insurance (end of period, fully loaded) | 6 171 | 6 171 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | - 27 | - 48 | - 28 | - 48 | 2 |
| Allocated capital (end of period) | 134 | 105 | 101 | 87 | 138 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 1 564 | 3 415 | 1 431 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 49 | - 84 | - 45 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 397 | 400 | 403 |
| or | ||||
| Average number of ordinary shares plus dilutive options less treasury shares in the period (D) |
397 | 400 | 403 | |
| Basic = (A-B) / (C) (in EUR) | 3.82 | 8.33 | 3.44 | |
| Diluted = (A-B) / (D) (in EUR) | 3.82 | 8.33 | 3.44 | |
Gives insight into the technical profitability of the short-term non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio is defined net of reinsurance.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Non-life PAA – Claims and claim related costs net of reinsurance (A) |
Note 3.6, component of 'Insurance Service Expenses' & of 'Non-directly attributable income and expenses' & of 'Net result from reinsurance contracts held' |
681 | 1 362 | 642 |
| + | ||||
| Costs other than claims and commissions (B) | Note 3.6, component of 'Insurance Service Expenses' & of 'Non-directly attributable income and expenses' & of 'Net result from reinsurance contracts held' |
385 | 729 | 349 |
| / | ||||
| Non-life PAA - Net earned expected premiums received (C) | Note 3.6, component of 'Insurance revenues before reinsurance' & of 'Net result from reinsurance contracts held' |
1 246 | 2 331 | 1 140 |
| = (A+B) / (C) | 85.5% | 89.7% | 87.0% |
A risk-weighted measure of the group's solvency based on common equity tier-1 capital (the ratios given here are based on the Danish compromise). Changes to the capital rules are gradually being implemented to allow banks to build up the necessary capital buffers. The capital position of a bank, when account is taken of the transition period, is referred to as the 'transitional' view. The capital position based on full application of all the rules – as would be the case after this transition period – is referred to as 'fully loaded'.
A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an impression of the relative cost efficiency (costs relative to income without bank and insurance tax, but including insurance commissions paid) of the group.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Total Opex without bank and insurance tax (A) | Consolidated income statement | 2 232 | 4 474 | 2 137 |
| + | ||||
| Insurance commissions paid (B) | Consolidated income statement | 206 | 383 | 181 |
| / | ||||
| Total income (C) | Consolidated income statement | 5 955 | 11 167 | 5 516 |
| =(A+B) / (C) | 40.9% | 43.5% | 42.0% | |
Where relevant, we also exclude the exceptional and/or non-operating items when calculating the cost/income ratio. This calculation aims to give a better idea of the relative cost efficiency of the pure business activities. The adjustments include: MTM ALM derivatives (fully excluded), bank and insurance taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 45% in 1H 2025 (versus 47% in 2024).
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. The numerator and denominator in the formula relate to all impaired loans, but may be limited to impaired loans that are more than 90 days past due (the figures for that particular calculation are given in the 'Credit risk' section.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Stage 3 impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
1 991 | 1 979 | 1 888 |
| / | ||||
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 041 | 4 171 | 4 265 |
| = (A) / (B) | 49.3% | 47.4% | 44.3% |
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) |
'Consolidated income statement': component of 'Impairment' |
158 | 207 | 94 |
| / | ||||
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
215 932 | 206 928 | 204 731 |
| = (A) (annualised) / (B) | 0.15% | 0.10% | 0.09% |
Note: a negative % is a release
*based on YTD view
In 1H 2025, the credit cost ratio without ECL for geopolitical and macroeconomic uncertainties, amounts to 0.15% (versus 0.16% in 2024).
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12. Where appropriate, the numerator in the formula may be limited to impaired loans that are more than 90 days past due (PD 11 + PD 12). Relevant figures for that calculation are given in the 'Credit Risk' section.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
4 041 | 4 171 | 4 265 |
| / | ||||
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
220 962 | 210 903 | 206 509 |
| = (A) / (B) | 1.8% | 2.0% | 2.1% |
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio. A detailed calculation can be found under 'Solvency KBC Group' section.
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period. It is the average of 12 end-of-month LCR figures.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) | Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
100 551 | 100 631 | 101 716 |
| / | ||||
| Total net cash outflows over the next 30 calendar days (B) |
64 142 | 63 588 | 63 699 | |
| = (A) / (B) | 157% | 158% | 160% | |
KBCs large stock of high-quality liquid assets (approximately 101 billion euros in 2Q 2025), which consist of cash and bonds which can be repoed in the private market and at the central banks. Note that the 101 billion euros consist of:
Gives an idea of the magnitude of (what are mainly traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
202 031 | 192 067 | 187 502 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions' |
1 856 | 424 | 895 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions (not with Central Banks) (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions' |
5 390 | 5 690 | 6 847 |
| + | ||||
| Other exposures to credit institutions (D) | 3 218 | 3 207 | 3 892 | |
| + | ||||
| Financial guarantees granted to clients and other commitments (E) |
Note 6.1, component of 'Financial guarantees given' |
11 023 | 10 476 | 10 153 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' |
2 489 | 2 455 | 2 439 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 1 794 | - 1 847 | - 1 902 |
| + | ||||
| Non-loan-related receivables (H) | - 684 | - 499 | - 569 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 2 568 | - 1 071 | - 2 748 |
| Gross Carrying amount = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) |
220 962 | 210 903 | 206 509 |
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
2 653 | 5 063 | 2 490 |
| / | ||||
| Average interest-bearing assets of the banking activities (B) | 'Consolidated balance sheet': component of 'Total assets' |
255 714 | 238 600 | 235 723 |
| = (A) (annualised x360/number of calendar days) / (B) | 2.06% | 2.09% | 2.09% |
The net interest margin is the net interest income of the banking activities, excluding dealing rooms and the net interest impact of ALM FX swaps and repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Regulation (EU) 2019/876 dd. 20-05-2019 | 226 899 | 221 939 | 216 102 |
| / | ||||
| Required amount of stable funding (B) | 168 465 | 159 835 | 155 072 | |
| = (A) / (B) | 135% | 139% | 139% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or number) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 23 339 | 22 447 | 21 185 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) |
Note 5.10 | 397 | 397 | 398 |
| = (A) / (B) (in EUR) | 58.85 | 56.60 | 53.18 |
KBC Group launched a share buyback program for the purpose of distributing the surplus capital from 11th August 2023 until 31st July 2024, for a maximum amount of 1.3 billion euros. At the end of September 2024, the total number of shares entitled to dividend reduced with 20 980 823 shares.
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 888 | 1 846 | 761 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
9 553 | 8 832 | 8 634 | |
| = (A) annualised / (B) | 18.6% | 20.9% | 17.6% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 447 | 858 | 441 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 396 | 2 133 | 2 100 | |
| = (A) annualised / (B) | 37.4% | 40.3% | 42.0% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) |
Note 2.2: Results by segment | 372 | 751 | 370 |
| / | ||||
| The average amount of capital allocated to the business unit is based on the risk-weighted assets for the banking activities (CRR/CRD) and risk-weighted asset equivalents for the insurance activities (under Solvency II) (B) |
2 797 | 2 710 | 2 700 | |
| = (A) annualised / (B) | 26.6% | 27.7% | 27.4% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) |
'Consolidated income statement' | 1 564 | 3 415 | 1 431 |
| + | ||||
| Coupon on the additional tier-1 instruments included in equity (B) |
'Consolidated statement of changes in equity' | - 49 | - 84 | - 45 |
| / | ||||
| Average parent shareholders' equity (C) | 'Consolidated statement of changes in equity' | 22 893 | 22 228 | 21 597 |
| = (A+B) (annualised) / (C) | 13.2% | 15.0% | 12.8% |
In 1H 2025, the return on equity amounts to 15% when including evenly spreading of the bank taxes throughout the year and excluding one-offs.
Total sales of life insurance compromise new business of guaranteed interest contracts, unit-linked investment contracts and hybrid contracts.
| Calculation (in millions of EUR or %) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Guaranteed Interest products | 632 | 1 219 | 483 | |
| + | ||||
| Unit-Linked products | 900 | 1 490 | 822 | |
| + | ||||
| Hybrid products | 136 | 197 | 80 | |
| Total sales Life (A) + (B) + (C) | 1 668 | 2 906 | 1 385 |
Measures the solvency of the insurance business, as calculated under Solvency II. A detailed calculation can be found under 'Solvency banking and insurance activities separately' section.
Total assets under management (AuM) consist of direct client money (Assets under Distribution towards retail, private banking and institutional clients), KBC Group assets (incl. pension fund), fund-of-funds assets and investment advice. Total AuM comprise assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence determine a large part of any change in this income line.
| Calculation (in billions of EUR or quantity) | Reference | 1H 2025 | 2024 | 1H 2024 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 248 | 245 | 234 |
| + | ||||
| Czech Republic Business Unit (B) | Company presentation on www.kbc.com | 21 | 19 | 18 |
| + | ||||
| International Markets Business Unit (C) | Company presentation on www.kbc.com | 12 | 11 | 10 |
| (A)+(B)+(C) | 280 | 276 | 262 |
Have a question? We'll get back to you promptly.